Quarterly Report • Dec 12, 2024
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group I Quarterly Report – 3Q2024 I p.1

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Analysis of the year-to-date period 9
ESG developments, risk statement and economic views 10
Our guidance 12
Consolidated income statement 14
Consolidated statement of comprehensive income 15
Consolidated balance sheet 16
Consolidated statement of changes in equity 17
Consolidated cash flow statement 19
Notes to the accounting policies 20
Notes on segment reporting 22
Other notes 24
Credit risk 39
Solvency 43
Income statement, volumes and ratios per business unit 49
Details of ratios and terms 57
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
'I Bartel Puelinckx, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
[email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 7 November 2024

| KBC Group – overview (consolidated, IFRS) | 3Q2024 | 2Q2024 | 3Q2023 | 9M2024 | 9M2023 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 868 | 925 | 877 | 2 300 | 2 725 |
| Basic earnings per share (in EUR) | 2.14 | 2.25 | 2.07 | 5.58 | 6.44 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 598 | 519 | 517 | 1 359 | 1 392 |
| Czech Republic | 179 | 244 | 200 | 620 | 661 |
| International Markets | 205 | 224 | 200 | 576 | 498 |
| Group Centre | -114 | -61 | -41 | -255 | 174 |
| Parent shareholders' equity per share (in EUR, end of period) | 54.1 | 53.2 | 52.2 | 54.1 | 52.2 |
We recorded a net profit of 868 million euros in the third quarter of 2024. Compared to the result for the previous quarter, our total income benefited from several factors, including higher net interest income (despite significantly lower income on inflation-linked bonds), increased insurance revenues supported by commercial actions, and higher net fee and commission income driven by excellent business performance. These items were offset by a decrease in trading & fair value income and the drop in dividend income following its seasonal peak in the second quarter.
Our loan portfolio continued to expand, increasing by 1% quarter-on-quarter and by 5% year-on-year. Customer deposits – excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches – were up 3% quarter-on-quarter and 5% year-on-year. As regards Belgium, deposits grew by as much as 5% quarter-on-quarter and 8% year-on-year, owing to the successful recuperation of customer funds following the maturity of the Belgian state note issued a year earlier. In fact, thanks to our proactive, multi-phased and multi-product customer offering, the total inflow of core customer money after the state note matured amounted to 6.5 billion euros, outpacing last year's 5.7-billion-euro outflow to the state note by 0.8 billion euros.
Operational expenses were up in the quarter under review but remained perfectly within our full-year 2024 guidance. Insurance service expenses were higher, partly as a result of the storms and floods in Central Europe, especially Storm Boris. To date, we are helping some 10 000 customers alleviate the impact of the floods caused by this storm. Next to that, we established a donation fund. Loan loss impairment charges, excluding the reserve for geopolitical and macroeconomic uncertainties, were up on the level recorded in the previous quarter, leading to a credit cost ratio of 16 basis points for the first nine months of 2024, substantially below the guidance. Including the reserve for geopolitical and macroeconomic uncertainties, the credit cost ratio stood at 10 basis points for the first nine months of 2024. In the quarter under review, we also booked a one-off 79-million-euros gain, under 'share in results of associated companies & joint ventures'.
Our solvency position remained strong, with a fully loaded common equity ratio of 15.2% at the end of September 2024. Our liquidity position remained very solid too, as illustrated by an LCR of 159% and NSFR of 142%. As already announced earlier, we will – in line with our general dividend policy – pay an interim dividend of 1 euro per share on 14 November 2024 as an advance on the total dividend for financial year 2024.
The share of bank and insurance products sold digitally has continued to rise: based on a selection of core products, around 55% of our banking and 29% of our insurance products were sold through a digital channel, up from 51% and 26% a year ago. And Kate, our personal digital assistant, is making good progress too: to date, over 5 million customers have already used Kate, an increase of no less than 37% on the year-earlier figure, while the proportion of cases resolved fully autonomously by Kate continues to improve and now stands at 67% in Belgium and 69% in the Czech Republic. I'm also delighted to add that our successful digitalisation and innovation journey regularly receives recognition from external parties. I am particularly proud that, just a few weeks ago, the independent international research agency Sia Partners honoured us by naming KBC Mobile the best mobile banking app in the world.
Our ultimate aim is to be the reference bank-insurer in all our core markets. This ambition is fuelled by our customer-centric business model and, most importantly, by the trust our customers, employees, shareholders, and other stakeholders place in us. We appreciate and are deeply grateful for this continued trust.

Johan Thijs Chief Executive Officer

• We place our customers at the centre of everything we do
• We look to offer our customers a unique bank-insurance experience

Net interest income increased by 1% both quarter-on-quarter and year-on-year. The net interest margin for the quarter under review amounted to 2.08%, down 1 basis point on the previous quarter and up 4 basis points on the year-earlier quarter. Customer loan volumes were up 1% quarter-on-quarter and 5% year-on-year. Customer deposits – excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches – were up 3% quarter-on-quarter and 5% year-on-year. In Belgium, the total inflow of core customer money (deposits, savings certificates, funds, insurance, bonds, etc.) after the state note matured totalled 6.5 billion euros and hence outpaced last year's 5.7-billion-euro outflow to the state note by 0.8 billion euros.
The insurance service result (insurance revenues before reinsurance - insurance service expenses before reinsurance + net result from reinsurance contracts held) amounted to 81 million euros (compared to 113 million euros and 138 million euros in the previous and year-earlier quarters, respectively) and breaks down into 45 million euros for non-life insurance and 36 million euros for life insurance. Our non-life insurance result was evidently impacted by Storm Boris in Central Europe. To date, we are helping some 10 000 customers alleviate the impact of the floods caused by this storm. We estimate the impact on the non-life result (after reinsurance) to be 33 million euros pre-tax in the quarter under review. The non-life insurance combined ratio for the first nine months of 2024 amounted to 89%, compared to 87% for full-year 2023. Non-life insurance sales increased by 8% year-on-year. Life insurance sales were excellent and were up 28% and 80% on the levels recorded in the previous and year-earlier quarters, respectively, due in both cases to higher sales of unit-linked and guaranteed-interest insurance products, thanks, among other things, to inflows from the maturing state note and a successful launch of structured emissions in Belgium.
Net fee and commission income was up 3% and 9% on its level in the previous and year-earlier quarters, respectively. In both cases, the increase came about thanks to the higher level of fees for our asset management activities and our banking services. Assets under management were up 3% quarter-on-quarter and 18% year-on-year.
Trading & fair value income and insurance finance income and expense was down 46 million euros and 34 million euros on the figures for the previous and year-earlier quarters, respectively. Net other income was slightly below its normal run rate. Dividend income was down on the previous quarter's level, as the second quarter traditionally includes the bulk of dividend income for the full year.
Operating expenses without bank and insurance taxes were up 6% and 3% on their level in the previous and the year-earlier quarters, respectively. The cost/income ratio for the first nine months of 2024 came to 47%, compared to 49% for full-year 2023. In that calculation, certain non-operating items have been excluded and bank and insurance taxes spread evenly throughout the year. Excluding all bank and insurance taxes, the cost/income ratio for the first nine months of 2024 amounted to 43%, fully in line with the figure for full-year 2023.
The quarter under review included a 61-million-euro net loan loss impairment charge, compared to 72 million euros in the previous quarter and 36 million euros in the year-earlier quarter. The credit cost ratio for the first nine months of 2024 amounted to 0.10%, compared to 0.00% for full-year 2023. Impairment on assets other than loans amounted to 7 million euros in the quarter under review, compared to 13 million euros in the previous quarter and 27 million euros in the year-earlier quarter.
The share in results of associated companies & joint ventures for the quarter under review included a 79-million-euros one-off gain related to Isabel.
Our liquidity position remained strong, with an LCR of 159% and NSFR of 142%. Our capital base remained robust, with a fully loaded common equity ratio of 15.2%.


Contribution of the business units
KBC Group I Quarterly Report – 3Q2024 I p.4

| KBC Group (simplified; in millions of EUR) | 3Q2024 | 2Q2024 | 1Q2024 | 4Q2023 | 3Q2023 | 9M2024 | 9M2023 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 394 | 1 379 | 1 369 | 1 360 | 1 382 | 4 141 | 4 113 |
| Insurance revenues before reinsurance | 740 | 726 | 714 | 683 | 699 | 2 181 | 1 996 |
| Non-life | 631 | 613 | 598 | 584 | 587 | 1 842 | 1 696 |
| Life | 109 | 114 | 116 | 99 | 113 | 339 | 301 |
| Dividend income | 11 | 26 | 7 | 12 | 10 | 44 | 47 |
| Net result from financial instruments at fair value through P&L and Insurance finance income and expense 1 |
-42 | 3 | -55 | -40 | -8 | -94 | 49 |
| Net fee and commission income | |||||||
| Net other income | 641 | 623 | 614 | 600 | 588 | 1 878 | 1 749 |
| 45 | 51 | 58 | 60 | 44 | 154 | 596 | |
| Total income Operating expenses (excl. directly attributable from |
2 787 | 2 809 | 2 708 | 2 674 | 2 715 | 8 303 | 8 550 |
| insurance) | -1 058 | -950 | -1 431 | -1 085 | -1 011 | -3 440 | -3 531 |
| Total operating expenses without bank and insurance taxes |
-1 135 | -1 074 | -1 063 | -1 169 | -1 101 | -3 272 | -3 269 |
| Total bank and insurance taxes | -47 | -2 | -518 | -36 | -29 | -568 | -651 |
| Minus: operating expenses allocated to insurance service expenses |
124 | 126 | 150 | 120 | 119 | 401 | 389 |
| Insurance service expenses before reinsurance | -688 | -590 | -563 | -567 | -540 | -1 840 | -1 553 |
| Of which Insurance commission paid | -99 | -92 | -89 | -94 | -87 | -280 | -246 |
| Non-Life | -615 | -514 | -489 | -509 | -485 | -1 618 | -1 361 |
| Life | -72 | -76 | -73 | -58 | -55 | -221 | -192 |
| Net result from reinsurance contracts held | 28 | -24 | -18 | -16 | -22 | -13 | -74 |
| Impairment | -69 | -85 | -16 | -170 | -63 | -170 | -46 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income2 |
-61 | -72 | -16 | 5 | -36 | -149 | 11 |
| Share in results of associated companies & joint ventures |
78 | 2 | 0 | 0 | 0 | 80 | -4 |
| Result before tax | 1 079 | 1 162 | 680 | 836 | 1 079 | 2 922 | 3 343 |
| Income tax expense | -211 | -237 | -175 | -159 | -203 | -623 | -619 |
| Result after tax | 868 | 925 | 506 | 677 | 877 | 2 299 | 2 725 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | -1 | -1 |
| attributable to equity holders of the parent Basic earnings per share (EUR) |
868 | 925 | 506 | 677 | 877 | 2 300 | 2 725 |
| Diluted earnings per share (EUR) | 2.14 2.14 |
2.25 2.25 |
1.18 1.18 |
1.59 1.59 |
2.07 2.07 |
5.58 5.58 |
6.44 6.44 |
| Key consolidated balance sheet figures, IFRS, KBC Group (in millions of EUR) |
30-09-2024 | 30-06-2024 | 31-03-2024 | 31-12-2023 | 30-09-2023 | ||
| Total assets | |||||||
| Loans & advances to customers | 353 261 | 361 945 | 359 477 | 346 921 | 358 453 | ||
| 188 623 | 187 502 | 183 722 | 183 613 | 181 821 | |||
| Securities (equity and debt instruments) | 75 929 | 73 941 | 73 561 | 73 696 | 72 765 | ||
| Deposits from customers3 | 221 851 | 221 844 | 216 314 | 216 501 | 214 287 | ||
| Insurance contract liabilities | 17 012 | 16 521 | 16 602 | 16 784 | 15 920 | ||
| Liabilities under investment contracts, insurance Total equity |
15 193 23 300 |
14 780 22 936 |
14 319 23 917 |
13 461 24 260 |
12 655 23 865 |
||
| Selected ratios KBC Group (consolidated) | 9M2024 | FY2023 | |||||
| Return on equity4 | 14% | 16% | |||||
| Cost/income ratio, group - excl. non-operating items and evenly spreading bank and insurance taxes throughout the year |
47% | 49% | |||||
| - excl. all bank and insurance taxes | 43% | 43% | |||||
| Combined ratio, non-life insurance | 89% | 87% | |||||
| Common equity ratio (CET1), Basel III, Danish Compromise. - fully loaded |
15.2% | 15.2% | |||||
| - transitional | 14.5% | 13.8% | |||||
| Credit cost ratio5 | 0.10% | 0.00% | |||||
| Impaired loans ratio for loans more than 90 days past due |
2.1% | 2.1% | |||||
| Net stable funding ratio (NSFR) | 1.1% 142% |
1.0% 136% |
1 As of 2024, we have combined 'Net result from financial instruments at fair value through P&L' (also referred to as 'Trading & fair value income') and 'Insurance finance income and expense' in one P&L line for the sake of simplification. The figures for past periods have been retroactively restated.
Also referred to as 'Loan loss impairment'. 3 Including customer savings certificates.
4 14% for the first nine months of 2024 and 15% for full-year 2023 when non-operating items are excluded and bank and insurance taxes evenly spread throughout the year.
5 A negative figure indicates a net impairment release (positively affecting results).

Net interest income amounted to 1 394 million euros in the quarter under review, up 1% both quarter-on-quarter and year-on-year. The 1% quarter-on-quarter increase was due to the higher commercial transformation result (thanks mainly to continued increasing reinvestment yields), a higher level of interest income from lending activities (the positive impact of loan volume growth was only partly offset by the negative impact of pressure on loan margins in some core markets) and lower costs related to the minimum required reserves held with central banks. These items were offset in part by lower interest income from inflation-linked bonds, a lower level of interest income from customer term deposits, and a lower level of interest income from short-term cash management activities.
The 1% year-on-year increase was attributable primarily to an increase in the commercial transformation result, a higher ALM result, the lower funding cost of participations and slightly higher level of income from lending activities. These items were partly offset by lower interest income in Ireland (following the sale of the loan and deposit portfolios and subsequent liquidation process), higher costs related to the minimum required reserves held with central banks, lower interest income from customer term deposits, higher wholesale funding costs, the lower level of interest income from short-term cash management activities, lower interest income from the dealing room, and a negative forex effect (depreciation of the Czech koruna and Hungarian forint).
The net interest margin for the quarter under review amounted to 2.08%, down 1 basis point quarter-on-quarter and up 4 basis points year-on-year. For guidance regarding expected net interest income in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
Customer loan volume (189 billion euros) was up 1% quarter-on-quarter and 5% year-on-year. At first sight, customer deposits (222 billion euros) were stable quarter-on-quarter and up 4% year-on-year. However, when excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches (driven by short-term cash management opportunities), customer deposits were up 3% quarter-on-quarter and 5% year-on-year. In Belgium, these figures amounted to 5% and 8%, respectively, which came about largely because of the successful recuperation of customer money following the maturity of the Belgian state note issued in September 2023. Thanks to our proactive, multi-phased and multi-product offer, we managed to attract a total of some 6.5 billion euros in core customer money in Belgium (deposits, savings certificates, funds, insurance, bonds, etc.), outpacing the 5.7-billion-euros outflow to the state note in September 2023 by 0.8 billion euros. The growth figures above exclude the forex-related impact. Note: the actions taken, amid fierce competition, to recover the outflow to the state note have an estimated direct negative impact on net interest income of roughly -87 million euros (-26 million euros in 2024 and -61 million euros in 2025). This direct negative impact is partly offset by various indirect positive impacts totalling approximately +20 million euros (in various P/L lines).
The insurance service result (insurance revenues before reinsurance – insurance service expenses before reinsurance + net result from reinsurance contracts held; the two latter items are not part of total income) amounted to 81 million euros and breaks down into 45 million euros for non-life insurance and 36 million euros for life insurance.
The non-life insurance service result decreased by 41% quarter-on-quarter and by 44% year-on-year, in both cases essentially owing to a combination of significantly higher insurance service expenses that were impacted by storms and floods (including Storm Boris in Central Europe – mainly the Czech Republic) and partly offset by higher insurance revenues and a better reinsurance result (related in part to the aforementioned storms and floods). We estimate the impact of the floods caused by Storm Boris (after reinsurance) to be 33 million euros pre-tax in the quarter under review.
The life insurance service result was more or less stable quarter-on-quarter (lower insurance service expenses offsetting lower insurance revenues) and down 38% year-on-year (higher level of insurance service expenses combined with slightly lower insurance revenues).
The combined ratio of the non-life insurance activities amounted to an excellent 89% for the first nine months of 2024, compared to 87% for full-year 2023. Non-life insurance sales came to 603 million euros and were up 8% year-on-year, with growth in all countries and all classes. Sales of life insurance products amounted to an excellent 791 million euros and were up 28% on the level recorded in the previous quarter (higher sales of guaranteed-interest products and, to a lesser extent, unit-linked products too, thanks, among other things, to inflows from the maturing state note and a successful launch of structured emissions in Belgium) and up 80% on the level recorded in the year-earlier quarter (higher sales of unit-linked products and, to a lesser extent, guaranteed-interest products and hybrid products too). Overall, the share of guaranteed-interest products and unit-linked products in our life insurance sales in the quarter under review amounted to 42% and 51%, respectively, with hybrid products (mainly in the Czech Republic) accounting for the remainder.
For guidance regarding expected insurance revenues and the combined ratio in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
Net fee and commission income amounted to 641 million euros, up 3% and 9% on its level in the previous and year-earlier quarters, respectively. The quarter-on-quarter increase was attributable to 3% growth in fee income from our asset management activities (largely related to the increase in assets under management, see below) and 4% growth in fees from our banking activities (thanks mainly to the – partly seasonal – increase in payment services fees). The 9% year-on-year increase in net fee and commission income was accounted for by 15% growth in fees for our asset management services and, to a lesser extent, a 3% rise in banking fees, slightly offset by a negative forex effect.
At the end of September 2024, our total assets under management amounted to 269 billion euros, up 3% quarter-on-quarter (+1 percentage point related to net inflows and +2 percentage points related to the quarter-on-quarter positive market performance). Assets under management grew by 18% year-on-year, with net inflows accounting for +5 percentage points and the positive market performance for +14 percentage points.
Trading & fair value income and insurance finance income and expense amounted to -42 million euros, down 46 million euros quarter-on-quarter and 34 million euros year-on-year. The quarter-on-quarter decrease was attributable to a number of factors, including negative market value adjustments (xVA). The year-on-year decrease was attributable mainly to negative market value adjustments, partly offset by higher dealing room income.
The other remaining income items included dividend income of 11 million euros (down on the 26 million euros recorded in the previous quarter, as the second quarter of the year traditionally includes the bulk of dividend income for the year) and net other income of 45 million euros, slightly below its (50-million-euro) normal run rate.
Operating expenses without bank and insurance taxes amounted to 1 135 million euros in the third quarter of 2024, up 6% on their level in the previous quarter and 3% year-on-year, and remained perfectly within our full-year 2024 guidance. The 6% quarter-onquarter increase was due in part to higher staff costs (mainly wage drift, partly offset by lower FTEs), ICT expenses, facilities expenses and depreciation charges. Operating expenses without bank and insurance taxes were up 3% on their year-earlier level, due primarily to higher staff costs (mainly inflation and wage indexation, partly offset by lower FTEs), ICT expenses and professional fees, partly offset by lower costs related to Ireland and a forex effect.
Bank and insurance taxes in the quarter under review amounted to 47 million euros, compared to 2 million euros in the previous quarter and 29 million euros in the year-earlier quarter. The quarter-on-quarter increase was accounted for mainly by increased national taxes (primarily in Hungary) and the fact that the previous quarter had included a partial reversal of the contribution to the deposit guarantee fund in Belgium due to a lower calculation base than anticipated by the government.
When certain non-operating items are excluded and bank and insurance taxes spread evenly throughout the year, the cost/income ratio for the first nine months of 2024 amounted to 47%, compared to 49% for full-year 2023. When excluding all bank and insurance taxes, the cost-income ratio improved to 43%, in line with the figure for full-year 2023.
For guidance regarding expected operating expenses and the cost/income ratio in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
versus a 72-million-euro net charge in the previous quarter and a 36-million-euro net charge in the year-earlier quarter
In the quarter under review, we recorded a 61-million-euro net loan loss impairment charge, compared to a net charge of 72 million euros in the previous quarter and 36 million euros in the year-earlier quarter. The net impairment charge in the quarter under review included a charge of 132 million euros in respect of our loan book (of which 54 million euros related to lowering the backstop shortfall for old non-performing loans in Belgium) and a reversal of 71 million euros following the update of the reserve for geopolitical and macroeconomic uncertainties. As a consequence, the outstanding reserve for geopolitical and macroeconomic uncertainties amounted to 168 million euros at the end of September 2024.
As a consequence, the credit cost ratio amounted to 0.10% for the first nine months of 2024 (0.16% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties), compared to 0.00% for full-year 2023 (0.07% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties). At the end of September 2024, 2.1% of our total loan book was classified as impaired ('Stage 3'), the same level as at year-end 2023. Impaired loans that are more than 90 days past due amounted to 1.1% of the loan book, compared to 1.0% as at year-end 2023.
For guidance regarding the expected credit cost ratio in and the years to come, please refer to the section entitled 'Our guidance'.
Impairment charges on assets other than loans amounted to 7 million euros, compared to 13 million euros in the previous quarter and 27 million euros in the year-earlier quarter. The quarter under review mainly included impairment charges related to software.
Belgium 598 million euros; Czech Rep. 179 million euros; International Markets 205 million euros, Group Centre -114 million euros
Belgium: the net result (598 million euros) was up 15% on the result for the previous quarter. This was due primarily to the combined effect of:
Czech Republic: the net result (179 million euros) was down 26% quarter-on-quarter (excluding forex effects). This was essentially attributable to a combination of:
International Markets: the 205-million-euro net result breaks down as follows: 16 million euros in Slovakia, 110 million euros in Hungary and 80 million euros in Bulgaria. For the business unit as a whole, the net result was down 8% on the previous quarter's result (down just 2% if bank and insurance taxes are excluded, see below), due mainly to a combination of:
Group Centre: the net result (-114 million euros) was 52 million euros lower than the figure recorded in the previous quarter owing mainly to a combination of:
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 9M2024 | FY2023 | 9M2024 | FY2023 | 9M2024 | FY2023 |
| Cost/income ratio - excl. non-operating items and spreading bank and insurance taxes evenly |
||||||
| throughout the year | 43% | 46% | 45% | 47% | 45% | 45% |
| - excl. all bank and insurance taxes |
41% | 41% | 43% | 44% | 37% | 39% |
| Combined ratio, non-life insurance | 87% | 85% | 87% | 84% | 97%2 | 97%2 |
| Credit cost ratio1 | 0.20% | 0.06% | -0.07% | -0.18% | -0.10% | -0.06% |
| Impaired loans ratio | 2.1% | 2.0% | 1.4% | 1.4% | 1.7% | 1.8% |
1 A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report.
2 Excluding windfall insurance taxes in Hungary, the combined ratio amounted to 92% for the first nine months of 2024 and 94% for full-year 2023.
At the end of September 2024, total equity came to 23.3 billion euros and comprised 21.4 billion euros in parent shareholders' equity and 1.9 billion euros in additional tier-1 instruments.
Total equity was down 1.0 billion euros on its level at the end of 2023. This was due to the combined effect of:
We have provided details of these changes under 'Consolidated statement of changes in equity' in the 'Consolidated financial statements' section of the quarterly report.
Note: in line with our general dividend policy, we will pay an interim dividend of 1 euro per share on 14 November 2024 as an advance on the total dividend for financial year 2024.
Our solvency position remained strong, as illustrated by a fully loaded common equity ratio (CET1) of 15.2% at 30 September 2024, unchanged on the 15.2% recorded at the end of 2023. The solvency ratio for KBC Insurance under the Solvency II framework was 197% at the end of September 2024, compared to 206% at the end of 2023. We have provided more details and additional information on solvency under 'Solvency' in the 'Additional information' section of the quarterly report.
Our liquidity position remained excellent too, as reflected in an LCR ratio of 159% and an NSFR ratio of 142%, compared to 159% and 136%, respectively, at the end of 2023, all well above the regulatory minima of 100%.

down 3% excluding the positive impact related to the sale of the Irish portfolio in the reference period
Highlights (compared to the first nine months of 2023, unless otherwise stated):

At KBC, we recognise the importance of transparently reporting on our sustainability efforts. Transparent disclosure is the cornerstone of action, forms the basis for future decision-making and drives our progress towards achieving sustainability goals. To this end, we continue to report on the progress we make in the area of sustainability. In the third quarter of 2024, for example, we again publicly disclosed our environmental data in line with CDP. We also disclosed the outcome of the 2024 S&P Global Corporate Sustainability Assessment, where we scored 66/100, placing us in the top 8% of the 664 banks assessed*. Additionally, we are currently in full preparation for first-time reporting under the Corporate Sustainability Reporting Directive (CSRD), which requires our company to report extensively on sustainability matters in a standardised manner in our next annual report.
* Includes 351 banks that, on 14 October 2024, were still assessed based on the 2023 methodology.
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of factors are considered to constitute the main challenges for the financial sector. These stem primarily from the mostly indirect, but lingering, impact of the war in Ukraine, including the delayed effects of the increase in energy and commodity prices and the supply-side shortages it triggered. This led to a surge in inflation, resulting in upward pressure on interest rates, lower growth prospects (or even fears of a recession) and some concerns about the creditworthiness of counterparties in the economic sectors most exposed. Geopolitical risks remain elevated, as evidenced by the escalating conflict in Gaza/Israel and the Middle East. A significant number of elections in 2024 across the world, including in the US, are adding to the geopolitical uncertainty. All these risks affect global, but especially, European economies, including KBC's home markets. Regulatory and compliance risks (including in relation to capital requirements, anti-money laundering regulations, GDPR and ESG/sustainability) also remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology, including AI, as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate and environmental-related risks are becoming increasingly prevalent (as recently evidenced by Storm Boris in Central Europe). Cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole. The war in Ukraine has triggered an increase in attacks worldwide. Finally, we have seen governments across Europe taking additional measures to support their budgets (via increased tax contributions from the financial sector) and their citizens and corporate sector (by, for instance, implementing interest rate caps on loans or by pushing for higher rates on savings accounts).
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
US growth in the third quarter amounted to 0.7%, the same as in the second quarter, driven primarily by private consumption. Growth is expected to moderate again to about 0.3% in the fourth quarter of 2024, when the labour market tightness is expected to ease further.
Euro area growth in the third quarter amounted to 0.4%, after 0.2% in the second quarter. The manufacturing sector continues to exhibit a persistent weakness, while the expected service sector recovery has not (yet) materialised. Growth is expected to continue at about its current pace, picking up in the second half of 2025 on the back of recovering domestic consumption.
Quarter-on-quarter growth in Belgium amounted to 0.2% in the third quarter, after 0.3% in the second quarter. Relatively strong domestic demand continued to outweigh the negative contribution to growth of net exports. For the remainder of 2024, we expect growth to remain broadly in line with that of the euro area.
The Czech economy grew by 0.3% in the third quarter, after 0.4% in the second quarter. This was supported by private consumption, against the background of a weak and delayed industrial recovery and the adverse economic impact of the flooding there. Weak growth of the industrial sector also weighed heavily on third-quarter growth in Hungary (-0.7%). Based on our latest estimates, thirdquarter growth in Bulgaria and Slovakia was relatively strong, amounting to 0.6% and 0.8%, respectively.
The main risk to our short-term outlook for European growth is the possible repercussion of the US elections in November. Moreover, the conflict in the Middle East poses the risk of higher energy and commodity prices. Other risks include the persistence of the current weakness of the global manufacturing sector. Specific European risk factors include the government budget discussions in the EU for 2025, which may generate increased uncertainty and hence adversely affect economic growth and temporarily raise risk premiums for vulnerable euro area member states.
Disinflation in the euro area and the US was broadly on track in the third quarter. In the euro area, inflation fell more than expected in September to . %, driven mainly by lower energy prices. However, inflation is expected to increase again in the period ahead. After January , inflation is expected to resume its downward trajectory towards the ECB's % target rate.
The ECB continued its easing cycle and cut its deposit rate in September and October by basis points each time. It is expected to cut this rate by another basis points in December . Further rate cuts are expected in .
In September, the Fed also started its easing cycle by cutting its policy rate by basis points. The si e of this rate cut was motivated by the weakness of labour market data at the time, which triggered a feeling of pessimism and fears of a recession. These disappeared when labour market data proved to be more resilient than feared. The Fed is expected to reduce its policy rate by basis points two more times in . Further rate cuts are expected in .
Ten year bond yields in the US and ermany gradually moved lower, before bottoming out in mid September. The main drivers were growth concerns relating mainly to the US labour market. When these concerns eased, bond yields rebounded markedly to their current level of about . % and . % in the US and ermany, respectively. This caused the US erman yield spread to sharply widen again. This yield spread was also the main driver of the US dollar euro exchange rate. The dollar gradually depreciated as the US erman yield spread narrowed. With the US erman spread widening again from the second half of October, the US dollar started to regain ground.
The Czech National Bank reduced its policy rate in two steps of 25 basis points each in the third quarter. Two more 25-basis-point rate cuts are expected by the end of 2024 and probably one more in the first quarter of 2025. Since the beginning of the third quarter, the Czech koruna has been relatively stable, underpinned primarily by global risk sentiment, interest rate differentials with the major central banks and the exchange rate with the US dollar. The koruna is expected to appreciate moderately in the coming quarters.
In the third quarter of 2024, the National Bank of Hungary cut its policy rate twice by 25 basis points each time. Additional gradual cuts are expected by the end of 2024 and in 2025. On balance, the Hungarian forint has depreciated against the euro and – driven by the structural positive inflation differential with the euro area – is expected to depreciate further in 2025.

Moving towards the Basel IV era and applying a static balance sheet (1H2024) and all other parameters ceteris paribus, without mitigating actions, KBC projects:
resulting in a fully loaded impact of +8.5 billion euros in risk-weighted assets (+8.0 billion euros previously).
| Agenda | Interim dividend of 1 euro: ex-coupon: 12 Nov. 2024, record: 13 Nov. 2024, payment: 14 Nov. 2024. 4Q2024 and FY2024 results: 13 Feb. 2025 Annual report FY2024: 31 Mar. 2025 AGM: 30 Apr. 2025 Other events: www.kbc.com / Investor Relations / Financial calendar |
|---|---|
| More information on 3Q2024 |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
Condensed interim consolidated financial statements according to IFRS
3Q 2024 and 9M 2024
AC: Amortised Cost ALM: Asset Liability Management AT1: Additional tier-1 instruments BBA: Building block approach CSM: Contractual service margin ECL: Expected Credit Loss FA: Financial Assets FV: Fair Value FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss GCA: Gross Carrying Amount HFT: Held For Trading IFIE: Insurance finance income and expense MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income OPEX: Operating expenses P&L: Income statement PAA: Premium allocation approach POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings UL: Unit linked VFA: Variable fee approach
Section reviewed by the Auditor
| (in millions of EUR) | Note | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 4 141 | 4 113 | 1 394 | 1 379 | 1 382 |
| Interest income | 3.1 | 15 127 | 14 779 | 4 901 | 5 103 | 5 399 |
| Interest expense | 3.1 | -10 985 | -10 666 | -3 508 | -3 724 | -4 017 |
| Insurance revenues before reinsurance | 3.6 | 2 181 | 1 996 | 740 | 726 | 699 |
| Non-life | 3.6 | 1 842 | 1 696 | 631 | 613 | 587 |
| Life | 3.6 | 339 | 301 | 109 | 114 | 113 |
| Dividend income | 44 | 47 | 11 | 26 | 10 | |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
3.3 | - 94 | 49 | - 42 | 3 | - 8 |
| Net result from financial instruments at fair value through profit or loss |
3.3 | 164 | 264 | 46 | 78 | 58 |
| Insurance finance income and expense (for insurance contracts issued) |
3.6 | - 258 | - 215 | - 88 | - 75 | - 67 |
| Net fee and commission income | 3.4 | 1 878 | 1 749 | 641 | 623 | 588 |
| Fee and commission income | 3.4 | 2 378 | 2 220 | 815 | 789 | 751 |
| Fee and commission expense | 3.4 | - 500 | - 471 | - 174 | - 166 | - 163 |
| Net other income | 3.5 | 154 | 596 | 45 | 51 | 44 |
| TOTAL INCOME | 8 303 | 8 550 | 2 787 | 2 809 | 2 715 | |
| Operating expenses (excluding opex allocated to insurance expenses) | 3.7 | -3 440 | -3 531 | -1 058 | - 950 | -1 011 |
| Total Opex without bank and insurance tax | 3.7 | -3 272 | -3 269 | -1 135 | -1 074 | -1 101 |
| Total bank and insurance tax | 3.7 | - 568 | - 651 | - 47 | - 2 | - 29 |
| Minus: Opex allocated to insurance service expenses | 3.7 | 401 | 389 | 124 | 126 | 119 |
| Insurance service expenses before reinsurance | 3.6 | -1 840 | -1 553 | - 688 | - 590 | - 540 |
| Of which insurance commissions paid | 3.6 | - 280 | - 246 | - 99 | - 92 | - 87 |
| Non-life | 3.6 | -1 618 | -1 361 | - 615 | - 514 | - 485 |
| Of which Non-life - Claim related expenses | 3.6 | -1 050 | - 829 | - 427 | - 331 | - 308 |
| Life | 3.6 | - 221 | - 192 | - 72 | - 76 | - 55 |
| Net result from reinsurance contracts held | 3.6 | - 13 | - 74 | 28 | - 24 | - 22 |
| Impairment | 3.9 | - 170 | - 46 | - 69 | - 85 | - 63 |
| on FA at amortised cost and at FVOCI | 3.9 | - 149 | 11 | - 61 | - 72 | - 36 |
| on goodwill | 3.9 | 0 | 0 | 0 | 0 | 0 |
| other | 3.9 | - 20 | - 56 | - 7 | - 13 | - 27 |
| Share in results of associated companies and joint ventures | 3.10 | 80 | - 4 | 78 | 2 | 0 |
| RESULT BEFORE TAX | 2 922 | 3 343 | 1 079 | 1 162 | 1 079 | |
| Income tax expense | 3.11 | - 623 | - 619 | - 211 | - 237 | - 203 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| RESULT AFTER TAX | 2 299 | 2 725 | 868 | 925 | 877 | |
| attributable to minority interests | - 1 | - 1 | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 2 300 | 2 725 | 868 | 925 | 877 | |
| Earnings per share (in EUR) | ||||||
| Ordinary | 5.58 | 6.44 | 2.14 | 2.25 | 2.07 | |
| Diluted | 5.58 | 6.44 | 2.14 | 2.25 | 2.07 |
In order to provide a more transparent view, we have combined the P&L lines 'Net result from financial instruments at fair value through profit or loss' and 'Insurance finance income and expense (for insurance contracts issued)'. In this way, the change in the fair value of the unit-linked liabilities, measured under IFRS 17 (Variable Fee Approach) (included in 'Insurance finance income and expense (for insurance contracts issued)') is offset by the change in the fair value of underlying unit-linked assets (included in 'Net result from financial instruments at fair value through profit or loss').
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 2 299 | 2 725 | 868 | 925 | 877 |
| Attributable to minority interests | - 1 | - 1 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 2 300 | 2 725 | 868 | 925 | 877 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | - 206 | 347 | - 58 | 4 | 18 |
| Net change in revaluation reserve (FVOCI debt instruments) | 33 | - 85 | 269 | - 136 | - 182 |
| Net change in hedging reserve (cashflow hedges) | 99 | 245 | 10 | 85 | 141 |
| Net change in translation differences | - 194 | - 40 | - 61 | 35 | - 202 |
| Hedge of net investments in foreign operations | 51 | 16 | 27 | - 18 | 32 |
| Net insurance finance income and expense from (re)insurance contracts issued |
- 195 | 212 | - 302 | 40 | 233 |
| Net insurance finance income and expense from reinsurance contracts held |
1 | 0 | 1 | - 1 | - 2 |
| Net change in respect of associated companies and joint ventures |
0 | 0 | 0 | 0 | 0 |
| Other movements | - 1 | - 1 | - 2 | - 1 | - 3 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | 196 | 79 | 8 | 36 | - 54 |
| Net change in revaluation reserve (FVOCI equity instruments) | 138 | 107 | - 6 | 30 | - 34 |
| Net change in defined benefit plans | 58 | - 29 | 14 | 7 | - 20 |
| Net change in own credit risk | 0 | 0 | 0 | 0 | 0 |
| Net change in respect of associated companies and joint | |||||
| ventures | 0 | 0 | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 2 289 | 3 150 | 818 | 966 | 840 |
| Attributable to minority interests | - 1 | - 1 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 2 289 | 3 150 | 818 | 966 | 840 |
The largest movements in other comprehensive income (9M 2024 and 9M 2023):
| (in millions of EUR) | Note | 30-09-2024 | 31-12-2023 |
|---|---|---|---|
| ASSETS | |||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 27 853 | 34 530 | |
| Financial assets | 4.0 | 318 376 | 306 047 |
| Amortised cost | 4.0 | 269 434 | 263 625 |
| Fair value through OCI | 4.0 | 21 787 | 18 587 |
| Fair value through profit or loss | 4.0 | 26 900 | 23 539 |
| of which held for trading | 4.0 | 9 771 | 8 327 |
| Hedging derivatives | 4.0 | 255 | 295 |
| Reinsurers' contract assets held | 125 | 64 | |
| Profit/loss on positions in portfolios hedged for interest rate risk | -1 924 | -2 402 | |
| Tax assets | 740 | 900 | |
| Current tax assets | 141 | 176 | |
| Deferred tax assets | 599 | 724 | |
| Non-current assets held for sale and disposal groups | 1 | 4 | |
| Investments in associated companies and joint ventures | 117 | 30 | |
| Property, equipment and investment property | 3 894 | 3 702 | |
| Goodwill and other intangible assets | 2 444 | 2 355 | |
| Other assets | 1 635 | 1 691 | |
| TOTAL ASSETS | 353 261 | 346 921 | |
| LIABILITIES AND EQUITY | |||
| Financial liabilities | 4.0 | 309 437 | 303 116 |
| Amortised cost | 4.0 | 287 770 | 280 874 |
| Fair value through profit or loss | 4.0 | 21 341 | 21 840 |
| of which held for trading | 4.0 | 5 111 | 7 050 |
| Hedging derivatives | 4.0 | 326 | 401 |
| Insurance contract liabilities | 5.6 | 17 012 | 16 784 |
| Non-life | 5.6 | 3 186 | 2 922 |
| Life | 5.6 | 13 827 | 13 862 |
| Profit/loss on positions in portfolios hedged for interest rate risk | - 263 | - 505 | |
| Tax liabilities | 448 | 472 | |
| Current tax liabilities | 84 | 99 | |
| Deferred tax liabilities | 364 | 373 | |
| Liabilities associated with disposal groups | 0 | 0 | |
| Provisions for risks and charges | 154 | 183 | |
| Other liabilities | 3 173 | 2 611 | |
| TOTAL LIABILITIES | 329 961 | 322 661 | |
| Total equity | 5.10 | 23 300 | 24 260 |
| Parent shareholders' equity | 5.10 | 21 435 | 22 010 |
| Additional tier-1 instruments included in equity | 5.10 | 1 864 | 2 250 |
| Minority interests | 0 | 0 | |
| TOTAL LIABILITIES AND EQUITY | 353 261 | 346 921 |
The increase of the total liabilities in 9M 2024 can for the largest part be explained by higher customer deposits and debt certificates and higher repos, partly offset by lower deposits from credit institutions and investment firms. The increase of customer deposits is driven mainly by the successful recuperation of the maturity of the Belgian state note issued in September 2023 (for more details see note 4.1).
The total assets increase in 9M 2024 can for the largest part be explained by higher loans and advances to customers and higher reverse repos, partly offset by lower cash and cash balances with central banks.
| Issued | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| and paid up |
Total | Parent | AT1 instruments |
||||||
| share | Share | Treasury | Retained | revaluation | shareholders' | included in | Minority | Total | |
| (in millions of EUR) | capital | premium | shares | earnings | reserves | equity | equity | interests | equity |
| 30-09-2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Restatement related to previous year(s) Restated balance at the beginning of the |
0 | 0 | 0 | - 41 | 0 | - 41 | 0 | 0 | - 41 |
| period | 1 461 | 5 548 | - 497 | 14 290 | 1 166 | 21 968 | 2 250 | 0 | 24 219 |
| Net result for the period | 0 | 0 | 0 | 2 300 | 0 | 2 300 | 0 | - 1 | 2 299 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 1 | - 9 | - 10 | 0 | 0 | - 10 |
| Subtotal | 0 | 0 | 0 | 2 299 | - 9 | 2 289 | 0 | - 1 | 2 289 |
| Dividends | 0 | 0 | 0 | - 1 941 | 0 | - 1 941 | 0 | 0 | - 1 941 |
| Coupon on AT1 | 0 | 0 | 0 | - 78 | 0 | - 78 | 0 | 0 | - 78 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | 0 | 0 | 0 | - 386 | 0 | - 386 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 38 | - 38 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 803 | 0 | 0 | - 803 | 0 | 0 | - 803 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total change | 0 | 0 | - 803 | 317 | - 47 | - 533 | - 386 | 0 | - 919 |
| Balance at the end of the period | 1 461 | 5 548 | - 1 300 | 14 607 | 1 119 | 21 435 | 1 864 | 0 | 23 300 |
| 2023 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 542 | 0 | 12 626 | 690 | 20 319 | 1 500 | 0 | 21 819 |
| Net result for the period | 0 | 0 | 0 | 3 402 | 0 | 3 402 | 0 | - 1 | 3 401 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 1 | 497 | 495 | 0 | 0 | 495 |
| Subtotal | 0 | 0 | 0 | 3 400 | 497 | 3 897 | 0 | - 1 | 3 896 |
| Dividends | 0 | 0 | 0 | - 1 663 | 0 | - 1 663 | 0 | 0 | - 1 663 |
| Coupon on AT1 | 0 | 0 | 0 | - 50 | 0 | - 50 | 0 | 0 | - 50 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | - 3 | 0 | - 3 | 750 | 0 | 747 |
| Capital increase | 0 | 6 | 0 | 0 | 0 | 7 | 0 | 0 | 7 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 21 | - 21 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 497 | 0 | 0 | - 497 | 0 | 0 | - 497 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | 6 | - 497 | 1 705 | 476 | 1 691 | 750 | 0 | 2 441 |
| Balance at the end of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| 30-09-2023 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 542 | 0 12 626 |
690 | 20 319 | 1 500 | 0 | 21 819 | |
| Net result for the period | 0 | 0 | 0 2 725 |
0 | 2 725 | 0 | - 1 | 2 725 | |
| OCI for the period | 0 | 0 | 0 - 1 |
426 | 425 | 0 | 0 | 425 | |
| Subtotal | 0 | 0 | 0 2 724 |
426 | 3 150 | 0 | - 1 | 3 150 | |
| Dividends | 0 | 0 | 0 - 1 666 |
0 | - 1 666 | 0 | 0 | - 1 666 | |
| Coupon on AT1 | 0 | 0 | 0 - 34 |
0 | - 34 | 0 | 0 | - 34 | |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 - 3 |
0 | - 3 | 750 | 0 | 747 | |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 29 |
- 29 | 0 | 0 | 0 | 0 | |
| Purchase/sale of treasury shares | 0 | 0 | - 152 | 0 | 0 | - 152 | 0 | 0 | - 152 |
| Change in minorities interests | 0 | 0 | 0 0 |
0 | 0 | 0 | 1 | 1 | |
| Total change | 0 | 0 | - 152 | 1 050 | 397 | 1 296 | 750 | 0 | 2 046 |
| Balance at the end of the period | 1 461 | 5 542 | - 152 | 13 677 | 1 087 | 21 614 | 2 250 | 0 | 23 865 |
The Annual General Meeting on 2 May 2024 approved a final gross dividend of 4.15 euros per share related to the accounting year 2023, of which:
• an interim dividend of 1.00 euro per share, as decided by KBC Group's Board of Directors of 9 August 2023 and paid on 15 November 2023 (was deducted from retained earnings in 3Q 2023)
• an ordinary dividend of 3.15 euros per share based on the outstanding number of shares entitled to dividend, which excludes the shares bought in the share buyback programme till the ex-coupon date of 13 May 2024 and paid on 15 May 2024, was deducted from retained earnings in 2Q 2024.
In line with our announced capital deployment plan for FY23, the Board of Directors decided to distribute the surplus capital above the fully loaded CET1 ratio of 15% in the form of an extraordinary interim dividend of 0.70 euros per share on 29 May 2024, which was also deducted from retained earnings in 2Q 2024.
Based on our general dividend policy, we will also pay out an interim dividend of 1 euro per share mid November 2024 as an advance on the total dividend for financial year 2024 (deducted from retained earnings in 3Q 2024).
Restatement related to previous year(s): adjustment of tax calculation in the Czech Republic. Given the relatively limited impact, the balance sheet and income statement for 2023 were not retroactively restated.
Issue/repurchase of AT1 included in equity: on 5 March 2024, KBC Group NV called the Additional Tier-1 Securities (AT1) issued in 2019 for 500 million euros. On 17 September 2024, KBC Group NV issued 750 million euros in AT1 Securities. On 18 September 2024, KBC Group NV announced the repurchase of part of the AT1 Securities issued in 2018 via a cash tender offer for an aggregate principal amount of 636 million euros. For more information, see note 5.10 further in this report.
Treasury shares: within the framework of the share buyback programme of 1.3 billion euros announced on 10 August 2023, the total number of own shares repurchased by KBC during to the programme amounted to 20 980 823 at 31 July 2024, completion date of the share buyback programme.
For more information: https://www.kbc.com/en/share-buy-back and Solvency section further in this report.
The 'Dividends' item in 2023 (1 663 million euros) includes the final dividend of 3.00 euros per share (1 252 million euros paid in May 2023) and the interim dividend of 1.00 euro per share (411 million euros paid in November 2023)
| Composition of the 'Total revaluation reserves' column in the previous table (in millions of EUR) | 30-09-2024 | 31-12-2023 | 30-09-2023 |
|---|---|---|---|
| Total | 1 119 | 1 166 | 1 087 |
| Revaluation reserve (FVOCI debt instruments) | - 563 | - 596 | -1 180 |
| Revaluation reserve (FVOCI equity instruments) | 322 | 222 | 162 |
| Hedging reserve (cashflow hedges) | - 480 | - 579 | - 692 |
| Translation differences | - 435 | - 240 | - 165 |
| Hedge of net investments in foreign operations | 177 | 127 | 91 |
| Remeasurement of defined benefit plans | 492 | 434 | 438 |
| Own credit risk through OCI | 0 | 0 | 0 |
| Insurance finance income and expense through OCI after reinsurance | 1 605 | 1 799 | 2 432 |
| (in millions of EUR) | Note | 9M 2024 | 9M 2023 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Result before tax | Cons. income stat. | 2 922 | 3 343 |
| Adjustments for non-cash items in profit & loss | 81 | - 608 | |
| Changes in operating assets (excluding cash and cash equivalents) | -11 789 | -4 914 | |
| Changes in operating liabilities (excluding cash and cash equivalents) | 8 255 | -4 460 | |
| Income taxes paid | - 481 | - 410 | |
| Net cash from or used in operating activities | -1 013 | -7 048 | |
| INVESTING ACTIVITIES | |||
| Purchase and proceeds of debt securities at amortised cost | 4.1 | 2 663 | -3 654 |
| Acquisition of a subsidiary or a business unit, net of cash acquired (including | |||
| increases in percentage interest held) | 0 | - 4 | |
| Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of (including decreases in percentage interest held) |
0 | 6 480 | |
| Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) | - 260 | - 242 | |
| Purchase and proceeds from the sale of property, plant and equipment (excluding | |||
| goodwill) | - 138 | - 225 | |
| Other | - 88 | 89 | |
| Net cash from or used in investing activities | 2 178 | 2 445 | |
| FINANCING ACTIVITIES | Cons. stat. of changes in | ||
| Purchase or sale of treasury shares | equity | - 803 | - 152 |
| Issue or repayment of promissory notes and other debt securities | 4.1 | - 158 | 6 197 |
| Proceeds from or repayment of subordinated liabilities | 4.1 | 926 | 511 |
| Cons. stat. of changes in | |||
| Proceeds from the issuance of share capital | equity | 0 | 0 |
| Issue or call of additional tier-1 instruments | Consolidated statement of changes in equity |
- 386 | 750 |
| Cons. stat. of changes in | |||
| Dividends paid | equity | -1 545 | -1 252 |
| Coupon additional Tier-1 instruments | Cons. stat. of changes in equity |
- 78 | - 34 |
| Net cash from or used in financing activities | -2 044 | 6 021 | |
| CHANGE IN CASH AND CASH EQUIVALENTS | |||
| Net increase or decrease in cash and cash equivalents | - 879 | 1 418 | |
| Cash and cash equivalents at the beginning of the period | 53 961 | 67 481 | |
| Effects of exchange rate changes on opening cash and cash equivalents | - 516 | - 78 | |
| Cash and cash equivalents at the end of the period | 52 566 | 68 821 | |
| COMPONENTS OF CASH AND CASH EQUIVALENTS | |||
| Cash and cash balances with central banks and other demand deposits with credit | Cons. | ||
| institutions | balance sheet | 27 853 | 42 373 |
| Term loans to banks at not more than three months (excl. reverse repos) | 4.1 | 549 | 1 264 |
| Reverse repos with credit institutions and investment firms at not more than three | |||
| months | 4.1 | 29 444 | 32 198 |
| Deposits from banks repayable on demand | 4.1 | -5 280 | -7 015 |
| Cash and cash equivalents belonging to disposal groups | 0 | 0 | |
| Total | 52 566 | 68 821 | |
| of which not available | 0 | 0 |
The net cash from operating activities in 9M 2024 (-1 013 million euros) mainly includes a decrease of deposits from credit institutions (including repayment of the remaining outstanding amount borrowed under TLTRO III (-2.6 billion euros)) and customer demand deposits, the decrease of certificates of deposits, the increase of loans and advances to costumers (mainly term and mortgage loans) and increase of the debt securities portfolio, partly offset by increased time deposits (for large part driven by the recuperation of the matured Belgian state note) and repos. The net cash from operating activities in 9M 2023 (-7 048 million euros) mainly includes an increasing mortgage and term loan portfolio, a significant decrease of deposits due to a repayment of part of the amount borrowed under TLTRO III (-12.9 billion euros in 9M 2023) as well as lower demand deposits and saving accounts (partly driven by outflow to Belgian state note). This is partly compensated by growth of certificates of deposit and time deposits.
Net cash from (used in) investing activities in 9M 2024 (+2 178 million euros) mainly includes net proceeds from debt securities at amortised cost (+2 663 million euros). Net cash from (used in) investing activities in 9M 2023 (+2 445 million euros) is mainly explained by the cash proceeds from closing of sale KBC Bank Ireland, partly offset by additional investments in debt securities at amortised cost.
The net cash flow from financing activities in 9M 2024 (-2 044 million euros) includes the dividend payment (-1 545 million euros), the decrease of Additional Tier-1 instruments (-386 million euros; for more information see note 5.10) and the purchase of treasury shares (-803 million euros) partly offset by the increase of new Tier-2 instruments (1 billion euros and 500 million British pounds issued versus 0.7 billion euros repaid). The net cash flow from financing activities in 9M 2023 (+6 021 million euros) mainly includes newly issued Senior Holdco instruments (+4.9 billion euros issued, partly offset by matured positions for -1 billion euros), higher outstanding covered bonds (+2 billion euros) and a newly issued Additional Tier-1 instrument (750 million euros) and Tier-2 instrument (500 million euros), partly compensated by the dividend payment (-1 252 million euros) and the share buyback (-152 million euros).
The condensed interim financial statements of the KBC Group for the period ended 30 September 2024 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2023, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards were issued but not yet effective in 2024. KBC will apply these standards when they become mandatory.
The IASB published several limited amendments to existing IFRSs and IFRICs. They will be applied when they become mandatory, but their impact is currently estimated to be negligible.
As of 1 January 2024, KBC has revised its multi-tier approach for the assessment of a significant increase in credit risk (please refer to Note 1.2: Summary of material accounting policies 'Significant increase in credit risk since initial recognition' in the annual accounts 2023). The indicators based on 12-months probability of default ('Internal rating' and 'Internal rating backstop') are replaced by an assessment based on lifetime probability of default and a watch list indicator. KBC applied the revised approach for the first time in 1Q 2024. This change in accounting estimate resulted in an ECL release of 17 million euros, included in Impairment on financial assets at amortised cost and at fair value through OCI (for more information see note 1.2).
Change to the presentation of the Consolidated income statement: see narrative below the Consolidated income statement.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2023. As mentioned in note 1.1 the paragraph regarding 'Significant increase in credit risk since initial recognition' has been updated as follows:
In accordance with the ECL model, financial assets attract life-time ECL once their credit risk increases significantly after initial recognition. Therefore, the assessment of a significant increase in credit risk defines the staging of financial assets. The assessment of a significant increase in credit risk is a relative assessment based on the credit risk that was assigned upon initial recognition. This is a multi-factor assessment and, therefore KBC has developed a multi-tier approach (MTA) for the bond portfolio on the one hand and for the loan portfolio on the other hand.
For the bond portfolio the MTA consists of three tiers:
environment (e.g. amongst others due to the coronavirus crisis), uncertainties about geopolitical events (e.g. due to an outbreak of a war) and the secondary impact of material defaults (e.g., on the suppliers, clients and employees of a defaulted company).
If none of these triggers results in a move to stage 2, the bond remains in stage 1. A financial asset is considered as stage 3 as soon as it meets the definition of default. The MTA is symmetrical, i.e. a bond that has moved into stage 2 or stage 3 can revert to stage 1 or stage 2 if the tier criterion that triggered the migration is not met on a subsequent reporting date.
For the loan portfolio KBC uses a five-tier approach. This MTA is a waterfall approach (, i.e. if assessing the first tier does not result in a move into stage 2, the second tier is assessed, and so on. In the end, if all tiers are assessed without triggering a migration to stage 2, the financial asset remains in stage 1.
A financial asset is considered as stage 3 as soon as it meets the definition of default. The MTA is symmetrical, i.e. a credit that has moved into stage 2 or stage 3 can revert to stage 1 or stage 2 if the tier criterion that triggered the migration is not met on a subsequent reporting date.
| Average exchange rate in 9M 2024 | ||||||
|---|---|---|---|---|---|---|
| Changes relative to 31-12-2023 | Changes relative to the average 9M 2023 | |||||
| 1 EUR = … | Positive: appreciation relative to EUR | 1 EUR = … | Positive: appreciation relative to EUR | |||
| … currency | Negative: depreciation relative to EUR | … currency | Negative: depreciation relative to EUR | |||
| CZK | 25.184 | -2% | 25.097 | -5% | ||
| HUF | 396.88 | -4% | 391.82 | -3% |
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2023.
As a result of the Irish sale transaction in February 2023, the results of KBC Bank Ireland in 2024 (included in Group Centre) have become immaterial and are hence not disclosed anymore separately as of 2024. Regarding the impact of the sale of the Irish loan and deposit portfolios to Bank of Ireland Group, see further in note 6.6.
| Czech | International | |||||||
|---|---|---|---|---|---|---|---|---|
| Belgium Business |
Republic Business |
Markets Business |
Of which: |
Group | ||||
| (in millions of EUR) | unit | unit | unit | Hungary | Slovakia | Bulgaria | Centre | Total |
| 9M 2024 | ||||||||
| Net interest income | 2 468 | 963 | 962 | 430 | 205 | 327 | - 251 | 4 141 |
| Insurance revenues before reinsurance | 1 335 | 433 | 402 | 153 | 80 | 169 | 11 | 2 181 |
| Non-life | 1 115 | 359 | 358 | 139 | 65 | 154 | 11 | 1 842 |
| Life | 220 | 74 | 45 | 15 | 15 | 15 | 0 | 339 |
| Dividend income | 38 | 1 | 1 | 0 | 0 | 1 | 4 | 44 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 230 | 43 | 48 | 44 | 5 | - 1 | 44 | - 94 |
| Net fee and commission income | 1 238 | 255 | 389 | 210 | 63 | 115 | - 3 | 1 878 |
| Net other income | 150 | 3 | 15 | 4 | 8 | 4 | - 14 | 154 |
| TOTAL INCOME | 4 999 | 1 698 | 1 816 | 841 | 362 | 614 | - 210 | 8 303 |
| Operating expenses (excluding Opex allocated to insurance service expenses) |
-1 907 | - 632 | - 776 | - 369 | - 198 | - 209 | - 125 | -3 440 |
| Total Opex without banking and insurance tax | -1 849 | - 675 | - 622 | - 216 | - 192 | - 214 | - 127 | -3 272 |
| Total Banking and insurance tax | - 285 | - 39 | - 245 | - 199 | - 26 | - 21 | 1 | - 568 |
| Minus: Opex allocated to insurance service expenses |
226 | 82 | 91 | 45 | 20 | 25 | 2 | 401 |
| Insurance service expenses before reinsurance | -1 064 | - 401 | - 373 | - 164 | - 84 | - 126 | - 3 | -1 840 |
| Of which insurance commissions paid | - 179 | - 52 | - 49 | - 10 | - 10 | - 29 | 0 | - 280 |
| Non-Life | - 910 | - 362 | - 343 | - 153 | - 73 | - 117 | - 3 | -1 618 |
| Of which Non-life - Claim related expenses | - 609 | - 245 | - 195 | - 77 | - 50 | - 68 | - 1 | -1 050 |
| Life | - 154 | - 38 | - 29 | - 10 | - 11 | - 8 | 0 | - 221 |
| Net result from reinsurance contracts held | - 53 | 50 | 3 | 9 | 2 | - 8 | - 14 | - 13 |
| Impairment | - 202 | 20 | 8 | 9 | 14 | - 15 | 4 | - 170 |
| of which on FA at AC and at fair value through OCI | - 198 | 21 | 25 | 24 | 14 | - 14 | 4 | - 149 |
| Share in results of associated companies and joint ventures | 80 | 0 | 0 | 0 | 0 | 0 | 0 | 80 |
| RESULT BEFORE TAX | 1 853 | 737 | 679 | 326 | 96 | 257 | - 348 | 2 922 |
| Income tax expense | - 495 | - 117 | - 103 | - 46 | - 20 | - 37 | 93 | - 623 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 1 358 | 620 | 576 | 280 | 76 | 220 | - 255 | 2 299 |
| attributable to minority interests | - 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 |
| attributable to equity holders of the parent | 1 359 | 620 | 576 | 280 | 76 | 220 | - 255 | 2 300 |
| Czech | International | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Belgium Business |
Republic Business |
Markets Business |
Of which: |
Group | Of which: |
||||
| (in millions of EUR) | unit | unit | unit | Hungary | Slovakia | Bulgaria | Centre | Ireland | Total |
| 9M 2023 | |||||||||
| Net interest income | 2 439 | 949 | 871 | 389 | 189 | 293 | - 146 | 50 | 4 113 |
| Insurance revenues before reinsurance | 1 222 | 414 | 351 | 141 | 71 | 139 | 10 | 0 | 1 996 |
| Non-life | 1 032 | 342 | 311 | 126 | 58 | 127 | 10 | 0 | 1 696 |
| Life | 190 | 71 | 40 | 15 | 12 | 12 | 0 | 0 | 301 |
| Dividend income | 42 | 1 | 1 | 0 | 0 | 1 | 3 | 0 | 47 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 112 | 51 | 47 | 38 | 6 | 3 | 64 | - 3 | 49 |
| Net fee and commission income | 1 144 | 244 | 365 | 191 | 63 | 112 | - 4 | - 1 | 1 749 |
| Net other income | 178 | 2 | 15 | 0 | 9 | 5 | 401 | 407 | 596 |
| TOTAL INCOME | 4 912 | 1 660 | 1 650 | 759 | 338 | 553 | 328 | 453 | 8 550 |
| Operating expenses (excluding Opex allocated to insurance service expenses) |
-1 949 | - 655 | - 741 | - 370 | - 170 | - 201 | - 186 | - 96 | -3 531 |
| Total Opex without banking and insurance tax | -1 820 | - 679 | - 585 | - 199 | - 184 | - 202 | - 184 | - 91 | -3 269 |
| Total Banking and insurance tax | - 353 | - 60 | - 234 | - 210 | - 4 | - 20 | - 4 | - 4 | - 651 |
| Minus: Opex allocated to insurance service expenses |
224 | 84 | 79 | 39 | 18 | 21 | 2 | 0 | 389 |
| Insurance service expenses before reinsurance | - 944 | - 307 | - 300 | - 141 | - 60 | - 98 | - 2 | 0 | -1 553 |
| Of which insurance commissions paid | - 163 | - 44 | - 39 | - 9 | - 7 | - 24 | - 1 | 0 | - 246 |
| Non-Life | - 811 | - 268 | - 279 | - 133 | - 53 | - 93 | - 2 | 0 | -1 361 |
| Of which Non-life - Claim related expenses | - 524 | - 156 | - 150 | - 63 | - 33 | - 53 | 0 | 0 | - 829 |
| Life | - 133 | - 39 | - 20 | - 9 | - 7 | - 5 | 0 | 0 | - 192 |
| Net result from reinsurance contracts held | - 44 | - 14 | - 14 | - 2 | - 3 | - 9 | - 2 | 0 | - 74 |
| Impairment | - 86 | 56 | - 13 | - 17 | 6 | - 1 | - 3 | - 5 | - 46 |
| of which on FA at AC and at fair value through OCI | - 71 | 56 | 18 | 12 | 6 | 0 | 8 | 6 | 11 |
| Share in results of associated companies and joint ventures | - 3 | - 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 4 |
| RESULT BEFORE TAX | 1 886 | 740 | 583 | 228 | 110 | 245 | 135 | 353 | 3 343 |
| Income tax expense | - 494 | - 79 | - 85 | - 37 | - 24 | - 25 | 39 | - 24 | - 619 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 1 392 | 661 | 498 | 191 | 87 | 220 | 174 | 328 | 2 725 |
| attributable to minority interests | - 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 |
| attributable to equity holders of the parent | 1 392 | 661 | 498 | 191 | 87 | 220 | 174 | 328 | 2 725 |
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| Total | 4 141 | 4 113 | 1 394 | 1 379 | 1 382 |
| Interest income | 15 127 | 14 779 | 4 901 | 5 103 | 5 399 |
| Interest income on financial instruments calculated using the effective interest rate method | |||||
| Financial assets at AC | 7 407 | 7 545 | 2 445 | 2 479 | 2 650 |
| Financial assets at FVOCI | 355 | 261 | 129 | 123 | 89 |
| Hedging derivatives | 4 628 | 3 579 | 1 517 | 1 553 | 1 556 |
| Financial liabilities (negative interest) | 4 | 9 | 0 | 2 | 2 |
| Other | 1 263 | 1 668 | 346 | 416 | 551 |
| Interest income on other financial instruments | |||||
| Financial assets MFVPL other than held for trading | 51 | 40 | 18 | 17 | 14 |
| Financial assets held for trading | 1 419 | 1 676 | 447 | 513 | 538 |
| Of which economic hedges | 1 268 | 1 554 | 389 | 464 | 490 |
| Other financial assets at FVPL | 0 | 0 | 0 | 0 | 0 |
| Interest expense | -10 985 | -10 666 | -3 508 | -3 724 | -4 017 |
| Interest expense on financial instruments calculated using the effective interest rate method |
|||||
| Financial liabilities at AC | -5 031 | -4 903 | -1 601 | -1 679 | -1 812 |
| Financial assets (negative interest) | - 1 | - 1 | 0 | 0 | 0 |
| Hedging derivatives | -4 553 | -3 735 | -1 498 | -1 533 | -1 604 |
| Other | - 4 | - 4 | - 1 | - 1 | - 1 |
| Interest expense on other financial instruments | |||||
| Financial liabilities held for trading | -1 349 | -1 979 | - 394 | - 495 | - 584 |
| Of which economic hedges | -1 313 | -1 942 | - 385 | - 483 | - 570 |
| Other financial liabilities at FVPL | - 51 | - 50 | - 15 | - 17 | - 18 |
| Net interest expense relating to defined benefit plans | 3 | 6 | 1 | 1 | 3 |
The interest income on financial instruments calculated using the effective interest rate method – other, is mainly related to interest income on cash balances with central banks. These cash and cash balances are mainly funded with short term liabilities, such as certificates of deposits and repos. The interest expense related to this funding is part of interest expense on financial liabilities at AC. Net interest margin on this activity is narrow, resulting in limited net interest income.
Central Banks decided to increase the Minimum Reserve Requirements (MRR) and/or reduce the remuneration on these deposits. This results in a negative impact on net interest income of about 46 million euros in 3Q 2024, compared to 51 million euros in 2Q 2024 and 31 million euros in 3Q 2023 (149 and 71 million euros respectively for 9M 2024 and 9M 2023).
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| Total | - 94 | 49 | - 42 | 3 | - 8 |
| Breakdown by driver | |||||
| Dealing room income | 226 | 210 | 62 | 61 | 47 |
| MTM ALM derivatives and other | - 117 | - 28 | - 16 | 1 | - 17 |
| Market value adjustments (xVA) | - 18 | 26 | - 24 | 1 | 17 |
| Result on investment backing UL contracts - under IFRS 17 & Insurance finance | |||||
| income and expense | - 183 | - 159 | - 63 | - 60 | - 56 |
Result on investment backing UL contracts - under IFRS 17 & Insurance finance income and expense: in order to provide a more transparent view, we have combined the P&L lines 'Net result from financial instruments at fair value through profit or loss' and 'Insurance finance income and expense (for insurance contracts issued)'. In this way, the change in the fair value of the unitlinked liabilities, measured under IFRS 17 (Variable Fee Approach) (included in 'Insurance finance income and expense (for insurance contracts issued)') is offset by the change in the fair value of underlying unit-linked assets (included in 'Net result from financial instruments at fair value through profit or loss'). The remaining amount mainly includes the interest accretion within IFIE (see note 3.6).
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 3Q 2024 is 46 million euros lower compared to 2Q 2024.
The quarter-on-quarter evolution is explained as follows:
Partly offset by:
• Slightly higher dealing room income in 3Q 2024 in Czech Republic and Hungary, more than compensating for slight decrease in Belgium
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 9M 2024 is 144 million euros lower compared to 9M 2023.
The year-on-year evolution is for a large part explained by:
Partly offset by:
• Higher dealing room income
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| Total | 1 878 | 1 749 | 641 | 623 | 588 |
| Fee and commission income | 2 378 | 2 220 | 815 | 789 | 751 |
| Fee and commission expense | - 500 | - 471 | - 174 | - 166 | - 163 |
| Breakdown by type | |||||
| Asset Management Services | 1 036 | 924 | 354 | 344 | 309 |
| Fee and commission income | 1 080 | 968 | 367 | 360 | 324 |
| Fee and commission expense | - 44 | - 44 | - 13 | - 16 | - 16 |
| Banking Services | 804 | 792 | 276 | 267 | 268 |
| Fee and commission income | 1 256 | 1 211 | 437 | 416 | 414 |
| Fee and commission expense | - 453 | - 419 | - 160 | - 149 | - 146 |
| Other | 38 | 33 | 11 | 12 | 12 |
| Fee and commission income | 42 | 41 | 12 | 13 | 13 |
| Fee and commission expense | - 4 | - 8 | - 1 | - 1 | - 1 |
• Asset Management Services include management fees, entry fees and distribution fees on mutual funds and unit-linked life products (under IFRS 9).
• Banking Services include credit- and guarantee related fees, payment service fees, network income, securities related fees, distribution fees banking products and other banking services.
• The distribution commissions paid regarding insurance contracts (life and non-life under IFRS 17) are presented in the income statement as Insurance Service Expenses (for more information, see note 3.7).
• The line Other includes distribution fees from third party insurance companies (not under IFRS 17) and platformication revenues.
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| Total | 154 | 596 | 45 | 51 | 44 |
| of which gains or losses on | |||||
| Sale of financial assets measured at amortised cost | - 28 | - 18 | - 10 | - 9 | - 12 |
| Sale of debt instruments at FVOCI | 0 | - 6 | 1 | 0 | - 7 |
| Repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 | 0 | 0 |
| of which other, including: | 182 | 620 | 54 | 60 | 63 |
| Income from operational leasing activities | 91 | 82 | 34 | 30 | 32 |
| Income from VAB Group | 34 | 29 | 12 | 9 | 8 |
| Legacy legal cases | 0 | - 2 | 0 | 0 | 0 |
| Gain on sale of KBC Bank Ireland's loan and deposit portfolios | 0 | 405 | 0 | 0 | 0 |
| Recovery of Belgian bank and insurance tax from 2016 (incl. moratorium interest) | 0 | 48 | 0 | 0 | 0 |
In 9M 2024:
• Realized loss on sale of low yielding bonds at amortised cost and FVOCI in Belgium, Czech Republic, Slovakia and Group Centre (total -27 million euros)
In 9M 2023:
The table below includes intragroup transactions between bank and insurance entities (the results for insurance contracts concluded between the group's bank and insurance entities, interest that insurance companies receive on their deposits with bank entities, distribution commissions intra-group…) in order to give a more accurate view of the profitability of the insurance business.
| of which life | |||||
|---|---|---|---|---|---|
| direct participating |
Non | ||||
| (in millions of EUR) | Life | (VFA) | Non-life | technical | Total |
| 9M 2024 | |||||
| Insurance service result | 118 | 8 | 229 | — | 347 |
| Insurance revenues before reinsurance | 339 | 18 | 1 849 | — | 2 188 |
| Insurance service expenses | - 221 | - 10 | - 1 620 | — | - 1 841 |
| Of which Non-life - Claim related expenses | — | — | - 1 051 | — | - 1 051 |
| Investment result and insurance finance income and expenses | 114 | 2 | 41 | 5 | 160 |
| Investment result | 339 | 76 | 74 | 5 | 418 |
| Net interest income | 243 | 0 | 68 | 0 | 311 |
| Dividend income | 17 | 0 | 3 | 5 | 25 |
| Net result from financial instruments at fair value through P&L | 75 | 75 | 0 | - 1 | 74 |
| Net other income | 2 | 0 | 3 | 1 | 6 |
| Impairment | 2 | 0 | 1 | 0 | 2 |
| Total insurance finance income and expenses before reinsurance |
- 226 | - 74 | - 33 | — | - 258 |
| Interest accretion | - 150 | — | - 34 | — | - 184 |
| Effect of changes in financial assumptions and foreign exchange | |||||
| differences | - 1 | 0 | 1 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 74 | - 74 | — | — | - 74 |
| Net insurance and investment result before reinsurance | 231 | 10 | 271 | 5 | 507 |
| Net result from reinsurance contracts held | - 4 | — | - 9 | — | - 13 |
| Premiums paid to the reinsurer | - 28 | — | - 92 | — | - 120 |
| Commissions received | 6 | — | 8 | — | 15 |
| Amounts recoverable from reinsurer | 18 | — | 76 | — | 93 |
| Total (ceded) reinsurance finance income and expense | 0 | — | - 1 | — | - 2 |
| Net insurance and investment result after reinsurance | 227 | 10 | 261 | 5 | 494 |
| Non-directly attributable income and expenses | 19 | - 1 | - 37 | 12 | - 6 |
| Net fee and commission income | 56 | 0 | - 1 | 23 | 78 |
| Net other income | — | — | — | 56 | 56 |
| Operating expenses (incl. banking and insurance tax) | - 36 | - 1 | - 36 | - 68 | - 140 |
| Impairment - Other | 0 | 0 | 0 | 0 | - 1 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 112 | - 112 |
| Result after tax | 247 | 9 | 224 | - 96 | 375 |
| Attributable to minority interest | — | — | — | — | — |
| Attributable to equity holders of the parent | — | — | — | — | 375 |
| of which life direct participating |
Non | ||||
|---|---|---|---|---|---|
| (in millions of EUR) | Life | (VFA) | Non-life | technical | Total |
| 9M 2023 | |||||
| Insurance service result | 108 | 10 | 341 | — | 449 |
| Insurance revenues before reinsurance | 301 | 19 | 1 704 | — | 2 004 |
| Insurance service expenses | - 192 | - 9 | - 1 363 | — | - 1 555 |
| Of which Non-life - Claim related expenses | — | — | - 831 | — | - 831 |
| Investment result and insurance finance income and expenses | 116 | 0 | 47 | 20 | 183 |
| Investment result on assets | 310 | 56 | 68 | 20 | 398 |
| Net interest income | 226 | 0 | 63 | 5 | 294 |
| Dividend income | 17 | 0 | 3 | 11 | 32 |
| Net result from financial instruments at fair value through P&L | 58 | 56 | 0 | 4 | 63 |
| Net other income | 8 | 0 | 1 | 0 | 9 |
| Impairment | 0 | 0 | 0 | 0 | 0 |
| Total insurance finance income and expenses before reinsurance |
- 194 | - 56 | - 21 | — | - 215 |
| Interest accretion | - 137 | — | - 21 | — | - 158 |
| Effect of changes in financial assumptions and foreign exchange differences |
- 1 | 0 | 0 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 56 | - 56 | — | — | - 56 |
| Net insurance and investment result before reinsurance | 224 | 10 | 389 | 20 | 632 |
| Net result from reinsurance contracts held | - 2 | — | - 72 | — | - 74 |
| Premiums paid to the reinsurer | - 23 | — | - 71 | — | - 94 |
| Commissions received | 5 | — | 7 | — | 11 |
| Amounts recoverable from reinsurer | 17 | — | - 6 | — | 11 |
| Total (ceded) reinsurance finance income and expenses | 0 | — | - 2 | — | - 2 |
| Net insurance and investment result after reinsurance | 222 | 10 | 317 | 20 | 559 |
| Non-directly attributable income and expenses | 7 | - 1 | - 32 | 8 | - 18 |
| Net fee and commission income | 50 | 0 | - 1 | 20 | 68 |
| Net other income | — | — | — | 49 | 49 |
| Operating expenses (incl. banking and insurance tax) | - 34 | - 1 | - 31 | - 60 | - 125 |
| Impairment - Other | - 9 | 0 | 0 | 0 | - 9 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 122 | - 122 |
| Result after tax | 229 | 9 | 285 | - 95 | 419 |
| Attributable to minority interest | — | — | — | — | 0 |
| Attributable to equity holders of the parent | — | — | — | — | 419 |
The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
The column 'of which life direct participating (VFA)' relates to results of long-term unit-linked contracts in Central and Eastern Europe.
Total insurance finance income and expenses before reinsurance includes changes in fair value of underlying assets of contracts measured under VFA, which represents the fair value movement of unit-linked liabilities, valued under IFRS 17 (variable fee approach), with the offsetting impact in fair value movement of underlying unit-linked assets in net result from financial instruments at fair value through profit or loss (see also note 3.3, result on investment backing UL contracts - under IFRS 17).
Amounts recoverable from reinsurer for Life also contains profit sharing (if any).
The insurance service expenses Non-life increased from -1 363 million euros in 9M 2023 to -1 620 million euros in 9M 2024 mainly due to higher claim related expenses (-220 million euros), which is a.o. due to impact of inflation, higher number of normal claims and the higher storm impact before reinsurance (mainly in 3Q 2024 related to storm Boris with a claim related impact of -71 million before reinsurance (for the largest part in the Czech Republic) and -33 million euros after reinsurance).
The total Operating expenses by nature include also Opex allocated to insurance service expenses (directly attributable to insurance) in order to provide a comprehensive overview of the total cost evolution.
| (in millions of EUR) | 9M 2024 | 9M 2023 | 3Q 2024 | 2Q 2024 | 3Q 2023 |
|---|---|---|---|---|---|
| Total Operating expenses by nature | -3 840 | -3 920 | -1 183 | -1 076 | -1 130 |
| Staff Expenses | -2 025 | -2 010 | - 683 | - 679 | - 682 |
| General administrative expenses | -1 533 | -1 619 | - 402 | - 305 | - 351 |
| ICT Expenses | - 464 | - 466 | - 168 | - 151 | - 164 |
| Facility Expenses | - 183 | - 193 | - 64 | - 59 | - 66 |
| Marketing & communication expenses | - 67 | - 69 | - 25 | - 23 | - 24 |
| Professional fees | - 100 | - 98 | - 35 | - 33 | - 29 |
| Bank and insurance tax | - 568 | - 651 | - 47 | - 2 | - 29 |
| Other | - 151 | - 142 | - 63 | - 36 | - 39 |
| Depreciation and amortisation of fixed assets | - 282 | - 291 | - 97 | - 93 | - 97 |
The operating expenses for 3Q 2024 include -47 million euros related to bank and insurance levies (-2 million euros in 2Q 2024; -29 million euros in 3Q 2023). Application of IFRIC 21 (Levies) has as a consequence that the majority of the levies are taken upfront in expense of the first quarter of the year.
The Belgian government decided in 3Q 2023 to increase the national bank taxes by: (1) higher bank taxes for deposits on the balance sheet above 50 billion euros (impact amounts to -28 million euros in 9M 2024, booked in 1Q 2024) and (2) abolishment of the income tax deductibility of the banking taxes (see note 3.11 further in this report).
Additionally, a further increase of the bank taxes was expected following an increase of the contribution to the Deposit Guarantee Scheme, amounting to -34 million euros booked upfront in 1Q 2024 (of which -28 million euros in Belgium). In 2Q 2024 the final invoice was 32 million euros lower (fully in Belgium), mainly as a result of lower covered deposits than anticipated by the Belgian government.
9M 2024 includes -71 million euros extraordinary sectoral tax in K&H Hungary (booked in 1Q 2024), compared to -101 million euros in 9M 2023 (respectively -79 and -22 million euros booked in 1Q 2023 and 2Q 2023). On 8 July 2024, the Hungarian government announced an increase of the financial transaction levy, resulting in -37 million euros booked in 3Q 2024 compared to -28 million euros in 2Q 2024.
Mid-January 2024 the Slovak Parliament introduced a special bank levy resulting in -25 million euros additional bank taxes in 9M 2024 (-8 million euros both in 1Q and 2Q 2024 and -9 million euros in 3Q24).
After reaching the target level of 1% of the covered deposits for the Single Resolution Fund in 2023, no annual contribution will be collected in 2024 in the eurozone countries (in 9M 2024 still -25 million euros related to contribution from non-eurozone countries, of which -27 million euros booked in 1Q 2024). In 9M 2023, the total contribution to the Single Resolution Fund amounted to -136 million euros.
The impairment on financial assets at AC and at FVOCI in 9M 2024 include:
• A net impairment release of 84 million euros for the geopolitical and macroeconomic uncertainties (of which 71 million euros release in 3Q 2024, 14 million euros charge in 2Q 2024 and 27 million euros release in 1Q 2024), compared to 120 million euros net impairment release in 9M 2023 (of which 59 million euros in 3Q 2023, 40 million euros in 2Q 2023 and 21 million euros in 1Q 2023).
The outstanding balance of ECL for the geopolitical and macroeconomic uncertainties amounts to 168 million euros at the end of 9M 2024. As a reminder, this is determined based on individual counterparties and sectors deemed to have incurred an increase in credit risk because they are either exposed to macroeconomic risks (high inflation, increasing interest rates, high(er) energy prices, supply chain disruption) or indirectly exposed to military conflicts, such as the one in Ukraine. The 71 million euros ECL release for geopolitical & macroeconomic uncertainties in 3Q 2024 is driven mainly by the positive evolution of micro- and macroeconomic indicators.
• Additionally, the impairments on financial assets at AC and at FVOCI in 9M 2024 include 233 million euros net charge (132 million euros in 3Q 2024 of which 54 million euros is reducing the backstop shortfall for old non-performing loans in Belgium, 58 million euros in 2Q 2024 and 43 million euros in 1Q 2024, largely in stage 3 mainly for a limited number of large corporate files in the business units Belgium and Czech Republic). In 9M 2023, the impairments on financial assets at AC and at FVOCI, include 109 million euros net charge (95 million euros in 3Q 2023, 17 million euros charge in 2Q 2023 and a net release of 3 million euros in 1Q 2023, related to a number of corporate and retail files mainly in Belgium and Bulgaria largely in stage 3).
The impairments on intangible asset (other than goodwill) in 9M 2024 (-4 million euros in 3Q 2024 and -8 million euros in 2Q 2024) and in 9M 2023 (-27 million euros mainly in 3Q 2023) are related to software impairments in Hungary and Belgium.
The impairments on property and equipment in 9M 2024 (-3 million euros) are related to bank office buildings and equipment in Belgium (in 3Q 2024). The impairments on property and equipment in 9M 2023 (-10 million euros) were related to the full write down of leased assets in Ireland (in 2Q 2023).
The impairment on other (Other) in 9M 2024 (-6 million euros, for a large part booked in 2Q 2024) and in 9M 2023 (-20 million euros, booked in 2Q 2023) are mainly related to modification losses, following the extension of the interest cap regulation for mortgages in Hungary until 31 December 2024 (and for 9M 2023 until 31 December 2023 for mortgages and SMEs).
The share in results of associated companies and joint ventures in 3Q 2024 includes a one-off gain of 79 million euros (related to Isabel NV).
In 2023, income tax expense was impacted by the non-tax deductibility as of 2023 (for 80%) of the Belgian national banking and insurance taxes, increasing the income tax expenses with about 36 million euros (impact fully in 1Q 2023). The Belgian government decided to abolish the remainder of the tax deductibility of the banking taxes (versus the current 20%) as of 2024, increasing the income tax expenses in 9M 2024 with about 11 million euros.
On 14 December 2023, Belgium, where ultimate parent company KBC Group NV has its registered office, laid down the Pillar Two global minimum tax in statute and declared that it would take effect on 1 January 2024. Under these rules, KBC is required to pay top-up tax (in Belgium or abroad) on the profits of its subsidiaries and permanent establishments, which are taxed at an effective tax rate of less than 15%. Based on the 9M 2024 results, the additional top-up tax amounts to roughly 17 million euros (mainly Bulgaria and the Czech Republic). The group has applied the temporary exception issued by the IASB in May 2023 relating to the accounting requirements for deferred taxes in IAS 12. The group will continue to monitor the effect of the Pillar Two legislation on its future financial performance.
Based on the approval received from the Irish Department of Finance on 13 September 2023, to transfer the remaining positions of KBC Bank Ireland to KBC Bank Dublin branch, which was implemented in December 2023, the main hurdles to start the legal liquidation process of KBC Bank Ireland have been taken. On 30 April 2024, KBC Bank Ireland returned its banking license to the Central Bank of Ireland. The aim is to close this liquidation process in the fourth quarter of 2024. The closing of the liquidation process can give rise to a tax deductible loss in KBC Bank NV in 2024 for which no deferred tax assets are yet recognized, as we consider this as a contingent asset at this moment subject to official authorization of the Irish tax authorities to liquidate KBC Bank Ireland (confirmation of no outstanding debt). This could lead to a tax benefit in P&L of 0.3 billion euros in the fourth quarter of 2024 at the earliest.
| Meas | |||||||
|---|---|---|---|---|---|---|---|
| ured at | |||||||
| fair value | Mandatorily | ||||||
| through | measured at | ||||||
| Meas ured at |
other compre |
fair value through profit |
Desig | ||||
| amor | hensive | or loss | Held for | nated at | Hedging | ||
| tised | income | (MFVPL) excl. | trading | fair value | deriva | ||
| (in millions of EUR) | cost (AC) | (FVOCI) | HFT | (HFT) | (FVO) | tives | Total |
| FINANCIAL ASSETS, 30-09-2024 | |||||||
| Loans and advances to credit institutions and investment | 2 578 | 0 | 0 | 1 | 0 | 0 | 2 579 |
| firms (excl. reverse repos) | |||||||
| of which repayable on demand and term loans at not | 549 | ||||||
| more than three months | |||||||
| Loans and advances to customers (excl. reverse repos) | 187 678 | 0 | 945 | 0 | 0 | 0 | 188 623 |
| Trade receivables | 2 589 | 0 | 0 | 0 | 0 | 0 | 2 589 |
| Consumer credit | 6 129 | 0 | 632 | 0 | 0 | 0 | 6 761 |
| Mortgage loans | 76 614 | 0 | 312 | 0 | 0 | 0 | 76 926 |
| Term loans | 88 266 | 0 | 1 | 0 | 0 | 0 | 88 266 |
| Finance lease | 7 760 | 0 | 0 | 0 | 0 | 0 | 7 760 |
| Current account advances | 5 366 | 0 | 0 | 0 | 0 | 0 | 5 366 |
| Other | 955 | 0 | 0 | 0 | 0 | 0 | 955 |
| Reverse repos | 29 815 | 0 | 0 | 439 | 0 | 0 | 30 253 |
| with credit institutions and investment firms | 29 703 | 0 | 0 | 439 | 0 | 0 | 30 142 |
| with customers | 111 | 0 | 0 | 0 | 0 | 0 | 111 |
| Equity instruments | 0 | 1 677 | 8 | 663 | 0 | 0 | 2 349 |
| Investment contracts (insurance) | 0 | 0 | 16 110 | 0 | 0 | 0 | 16 110 |
| Debt securities issued by | 48 394 | 20 110 | 65 | 5 011 | 0 | 0 | 73 580 |
| Public bodies | 40 562 | 15 837 | 0 | 3 917 | 0 | 0 | 60 317 |
| Credit institutions and investment firms | 5 643 | 2 380 | 0 | 1 018 | 0 | 0 | 9 041 |
| Corporates | 2 189 | 1 893 | 65 | 75 | 0 | 0 | 4 222 |
| Derivatives | 0 | 0 | 0 | 3 657 | 0 | 255 | 3 912 |
| Other | 969 | 0 | 0 | 0 | 0 | 0 | 969 |
| Total | 269 434 | 21 787 | 17 128 | 9 771 | 0 | 255 | 318 376 |
| FINANCIAL ASSETS, 31-12-2023 | |||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
2 779 | 0 | 0 | 1 | 0 | 0 | 2 779 |
| of which repayable on demand and term loans at not | 222 | ||||||
| more than three months | |||||||
| Loans and advances to customers (excl. reverse repos) | 182 777 | 0 | 836 | 0 | 0 | 0 | 183 613 |
| Trade receivables | 2 680 | 0 | 0 | 0 | 0 | 0 | 2 680 |
| Consumer credit | 6 604 | 0 | 608 | 0 | 0 | 0 | 7 211 |
| Mortgage loans | 75 254 | 0 | 228 | 0 | 0 | 0 | 75 482 |
| Term loans | 85 694 | 0 | 0 | 0 | 0 | 0 | 85 694 |
| Finance lease | 7 197 | 0 | 0 | 0 | 0 | 0 | 7 197 |
| Current account advances | 4 626 | 0 | 0 | 0 | 0 | 0 | 4 626 |
| Other | 723 | 0 | 0 | 0 | 0 | 0 | 723 |
| Reverse repos | 25 501 | 0 | 0 | 0 | 0 | 0 | 25 501 |
| with credit institutions and investment firms | 25 356 | 0 | 0 | 0 | 0 | 0 | 25 356 |
| with customers | 144 | 0 | 0 | 0 | 0 | 0 | 144 |
| Equity instruments | 0 | 1 695 | 14 | 570 | 0 | 0 | 2 279 |
| Investment contracts (insurance) | 0 | 0 | 14 348 | 0 | 0 | 0 | 14 348 |
| Debt securities issued by | 51 372 | 16 892 | 14 | 3 138 | 0 | 0 | 71 417 |
| Public bodies | 43 337 | 13 206 | 0 | 2 966 | 0 | 0 | 59 509 |
| Credit institutions and investment firms | 5 658 | 1 826 | 0 | 12 | 0 | 0 | 7 496 |
| Corporates | 2 377 | 1 861 | 14 | 160 | 0 | 0 | 4 412 |
| Derivatives | 0 | 0 | 0 | 4 618 | 0 | 295 | 4 914 |
| Other | 1 196 | 0 | 0 | 0 | 0 | 0 | 1 196 |
| Total | 263 625 | 18 587 | 15 212 | 8 327 | 0 | 295 | 306 047 |
| Measured at | Held for | ||||
|---|---|---|---|---|---|
| amortised cost | trading | Designated at fair | Hedging | ||
| (in millions of EUR) FINANCIAL LIABILITIES, 30-09-2024 |
(AC) | (HFT) | value (FVO) | derivatives | Total |
| Deposits from credit institutions and investment firms | |||||
| (excl. repos) | 11 742 | 0 | 0 | 0 | 11 742 |
| of which repayable on demand | 5 280 | ||||
| Deposits from customers and debt securities (excl. repos) |
261 924 | 83 | 1 063 | 0 | 263 071 |
| Demand deposits | 103 558 | 0 | 0 | 0 | 103 558 |
| Time deposits | 45 040 | 83 | 242 | 0 | 45 366 |
| Savings accounts | 71 696 | 0 | 0 | 0 | 71 696 |
| Savings certificates | 1 232 | 0 | 0 | 0 | 1 232 |
| Subtotal, customer deposits | 221 526 | 83 | 242 | 0 | 221 851 |
| Certificates of deposit | 13 980 | 0 | 5 | 0 | 13 985 |
| Non-convertible bonds | 22 799 | 0 | 704 | 0 | 23 503 |
| Non-convertible subordinated liabilities | 3 619 | 0 | 111 | 0 | 3 730 |
| Repos | 10 944 | 84 | 0 | 0 | 11 028 |
| with credit institutions and investment firms | 5 555 | 84 | 0 | 0 | 5 639 |
| with customers | 5 389 | 0 | 0 | 0 | 5 389 |
| Liabilities under investment contracts | 26 | 0 | 15 167 | 0 | 15 193 |
| Derivatives | 0 | 4 310 | 0 | 326 | 4 636 |
| Short positions | 0 | 633 | 0 | 0 | 633 |
| In equity instruments | 0 | 15 | 0 | 0 | 15 |
| In debt securities | 0 | 618 | 0 | 0 | 618 |
| Other | 3 135 | 0 | 0 | 0 | 3 135 |
| Total | 287 770 | 5 111 | 16 230 | 326 | 309 437 |
| FINANCIAL LIABILITIES, 31-12-2023 | |||||
| Deposits from credit institutions and investment firms | |||||
| (excl. repos) | 15 013 | 0 | 0 | 0 | 15 013 |
| of which repayable on demand | 6 136 | ||||
| Deposits from customers and debt securities (excl. repos) |
258 051 | 81 | 1 359 | 0 | 259 491 |
| Demand deposits | 107 568 | 0 | 0 | 0 | 107 568 |
| Time deposits | 37 770 | 81 | 194 | 0 | 38 044 |
| Savings accounts | 70 810 | 0 | 0 | 0 | 70 810 |
| Savings certificates | 79 | 0 | 0 | 0 | 79 |
| Subtotal, customer deposits | 216 227 | 81 | 194 | 0 | 216 501 |
| Certificates of deposit | 16 840 | 0 | 6 | 0 | 16 846 |
| Non-convertible bonds | 22 294 | 0 | 1 045 | 0 | 23 339 |
| Non-convertible subordinated liabilities | 2 690 | 0 | 114 | 0 | 2 804 |
| Repos | 5 235 | 40 | 0 | 0 | 5 275 |
| with credit institutions and investment firms | 3 259 | 40 | 0 | 0 | 3 298 |
| with customers | 1 976 | 0 | 0 | 0 | 1 976 |
| Liabilities under investment contracts | 29 | 0 | 13 432 | 0 | 13 461 |
| Derivatives | 0 | 5 501 | 0 | 401 | 5 902 |
| Short positions | 0 | 1 428 | 0 | 0 | 1 428 |
| In equity instruments | 0 | 6 | 0 | 0 | 6 |
| In debt securities | 0 | 1 421 | 0 | 0 | 1 421 |
| Other | 2 546 | 0 | 0 | 0 | 2 547 |
| Total | 280 874 | 7 050 | 14 791 | 401 | 303 116 |
Deposits from credit institutions and investment firms: includes funding from the ECB's TLTRO programme. In 2023 an amount of 12.9 billion euros was repaid (of which 10.9 billion euros at maturity in 2Q 2023 and 2 billion euros in 1Q 2023). In 1H 2024 the last remaining parts matured (an amount of 2.2 billion euros in 1Q 2024 and 0.4 billion euros in 2Q 2024).
In September 2024, the state note issued by the Kingdom of Belgium with a tenor of 1 year for an amount of 22 billion euros, came to maturity, initiating temporary special offers by banks in Belgium in order to attempt to recover the money. For KBC this resulted in a net inflow of core customer money of 6.5 billion euros in 3Q 2024 (of which 6.0 billion euros time deposits, 1.2 billion euros saving certificates and 0.9 billion other inflows (i.e. mutual funds and Life insurance products), partly offset by a transfer from demand and saving deposits of -1.6 billion euros), compared to an outflow to the state note of 5.7 billion euros in 3Q 2023. Note that following the relaunch of the (retail) saving certificates in Belgium, this product is now retroactively included as part of the subtotal of customer deposits.
| Carrying value before | Carrying value after | ||
|---|---|---|---|
| (in millions of EUR) | impairment | Impairment | impairment |
| 30-09-2024 FINANCIAL ASSETS AT AMORTISED COST |
|||
| Loans and advances * | 222 551 | - 2 479 | 220 071 |
| Stage 1 (12-month ECL) | 192 368 | - 147 | 192 220 |
| Stage 2 (lifetime ECL) | 26 197 | - 402 | 25 795 |
| Stage 3 (lifetime ECL) | 3 529 | - 1 808 | 1 721 |
| Purchased or originated credit impaired assets (POCI) | 456 | - 122 | 334 |
| Debt Securities | 48 402 | - 8 | 48 394 |
| Stage 1 (12-month ECL) | 48 306 | - 6 | 48 300 |
| Stage 2 (lifetime ECL) | 92 | - 1 | 91 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 20 114 | - 4 | 20 110 |
| Stage 1 (12-month ECL) | 20 098 | - 4 | 20 094 |
| Stage 2 (lifetime ECL) | 17 | 0 | 16 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| 31-12-2023 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 213 531 | - 2 474 | 211 057 |
| Stage 1 (12-month ECL) | 175 853 | - 146 | 175 708 |
| Stage 2 (lifetime ECL) | 33 571 | - 490 | 33 081 |
| Stage 3 (lifetime ECL) | 3 694 | - 1 750 | 1 944 |
| Purchased or originated credit impaired assets (POCI) | 412 | - 88 | 324 |
| Debt Securities | 51 384 | - 12 | 51 372 |
| Stage 1 (12-month ECL) | 51 300 | - 6 | 51 294 |
| Stage 2 (lifetime ECL) | 80 | - 4 | 76 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 16 897 | - 5 | 16 892 |
| Stage 1 (12-month ECL) | 16 864 | - 4 | 16 861 |
| Stage 2 (lifetime ECL) | 33 | - 1 | 32 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
(*) The carrying value after impairment in this note is equal to the sum of the lines Loans and advances to credit institutions and investment firms (excl. reverse repos), Loans and advances to customers (excl. reverse repos) and Reverse repos in note 4.1 (in the column Measured at amortised cost)
A collective shift (since 2022) of an exposure of 12.2 billion euros from stage 1 to stage 2 has been applied at 30 September 2024, compared to 12.0 billion euros at 31 December 2023. It concerns stage 1 portfolios that are either:
In 9M 2024 a combined net stage shift from stage 2 to stage 1 has taken place of approximately 8.5 billion euros in gross carrying amount with a net ECL release of 17 million euros (fully booked in 1Q 2024). For the majority this is caused by the implementation of the new multi-tier approach for staging (see note 1.2) and for the remainder by a shift for KBC Commercial Finance exposure in Belgium where the relative change in credit risk has been revisited based on the very low historical credit losses in this portfolio and taking into account the very short maturities. Both movements were introduced to better reflect the underlying credit risk since origination.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2023.
| (in millions of EUR) | 30-09-2024 | 31-12-2023 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
16 042 | 81 | 1 005 | 17 128 | 14 253 | 107 | 851 | 15 212 |
| Held for trading | 3 642 | 5 151 | 979 | 9 771 | 2 991 | 4 625 | 711 | 8 327 |
| Designated at fair value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| At fair value through OCI | 18 950 | 2 224 | 646 | 21 819 | 15 290 | 2 628 | 669 | 18 587 |
| Hedging derivatives | 0 | 255 | 0 | 255 | 0 | 295 | 0 | 295 |
| Total | 38 633 | 7 711 | 2 630 | 48 974 | 32 534 | 7 656 | 2 231 | 42 422 |
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||
| Held for trading | 635 | 3 125 | 1 351 | 5 111 | 1 429 | 4 582 | 1 039 | 7 050 |
| Designated at fair value | 15 167 | 265 | 798 | 16 230 | 13 432 | 202 | 1 157 | 14 791 |
| Hedging derivatives | 0 | 255 | 71 | 326 | 0 | 306 | 95 | 401 |
| Total | 15 802 | 3 646 | 2 220 | 21 667 | 14 862 | 5 090 | 2 290 | 22 242 |
During 9M 2024, KBC transferred about 180 million euros worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 415 million euros worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 9M 2024 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
The Contractual Service Margin (CSM) as included in the insurance contract liabilities, evolved from 2 244 million euros at the end of 2023 to 2 255 million euros at 30 September 2024, or an increase of 11 million euros. In 2Q 2024, a migration of Belgian contracts of individual pension agreements from the portfolio 'Risk and Savings' towards the portfolio 'Hybrid products' has been performed as the policyholders are offered the option to invest in Class 23. The net impact on the CSM is an increase of 96 million euros in 2Q 2024.
Excluding the migration, there is a decrease in CSM of 85 million euros compared to the end of 2023, which is mainly driven by negative change in best estimates reflected in the CSM (-108m; mainly driven by parameter updates and changes in noneconomic & experience variances), while CSM of new business (+131 million euros) was slightly higher compared to the CSM release in the income statement (-118 million euros).
| Quantities | 30-09-2024 | 31-12-2023 |
|---|---|---|
| Ordinary shares | 417 305 876 | 417 305 876 |
| of which ordinary shares that entitle the holder to a dividend payment | 396 325 051 | 408 508 807 |
| of which treasury shares | 20 980 825 | 8 801 316 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on Euronext Brussels.
The treasury shares almost entirely relate to shares bought in the share buyback programme.
In September 2023, KBC Group NV issued Additional Tier-1 securities for 750 million euros (perpetual with a first callable after 5 years; temporary write-down trigger should the common equity ratio fall below 5.125%; initial coupon of 8.00% per year payable every six months).
In March 2024, KBC Group NV called the Additional Tier-1 securities it issued in 2019. The European Central Bank (ECB) granted KBC permission to call this instrument, which had a nominal value of 500 million euros, and at the same time to call the subordinated inter-company loan of the same amount that KBC Group NV granted to KBC Bank NV.
In September 2024, KBC Group NV issued Additional Tier-1 securities for 750 million euros (perpetual with a first callable after 5 years; temporary write-down trigger should the common equity ratio fall below 5.125%; initial coupon of 6.25% per year payable every six months). Additionally, KBC Group NV announced the repurchase of part of the Additional Tier-1 securities issued in 2018 via a cash tender offer for an aggregate principal amount of 636 million euros.
KBC has in the years 2016-2022 provided irrevocable payment commitments (IPC's) for an amount of 90 million euros to the Single Resolution Fund (SRF) which are covered fully by cash collateral. In line with industry practice, following accounting treatment is applied to IPC's:
The recognition of the cash collateral as a financial asset is based on the consideration that, in any scenario, the collateral should be returned to the bank and that interest is received on the amount outstanding. In 4Q 2023, the General Court of the EU ruled that in a scenario in which a bank loses its banking license, it has no claim on the cash collateral. KBC decided to await the outcome of the appeal in this case at the European Court of Justice before considering the potential implications on the accounting treatment of IPC's.
The 90 million euros is deducted in the calculation of the common equity capital (CET1).
On 3 February 2023, KBC Bank Ireland closed the sale of substantially all of its assets and liabilities to Bank of Ireland Group. The transaction had an impact on KBC Group's P&L (1Q 2023) of +0.4 billion euros (for more information on the impact on the P&L of 2022 and 2023, see note 6.6 in the Annual report of 2023). On 30 April 2024, KBC Bank Ireland returned its banking license to the Central Bank of Ireland.
Significant non-adjusting events between the balance sheet date (30 September 2024) and the publication of this report (7 November 2024): None


Additional Information
3Q 2024 and 9M 2024
Section not reviewed by the Auditor
The main source of credit risk is the loan portfolio of the bank. It includes all the loans and guarantees that KBC has granted to individuals, companies, governments and banks. Debt securities in the investment portfolio are included if they are issued by companies or banks. Government bonds are not included. The loan portfolio as defined in this section differs from 'Loans and advances to customers' in Note 4.1 of the 'Consolidated financial statements' section of the annual accounts 2023. For more information, please refer to 'Details of ratios and terms on KBC Group level'.
A snapshot of the banking portfolio is shown in the table below. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit.
| Credit risk: loan portfolio overview | 30-09-2024 | 31-12-2023 |
|---|---|---|
| Total loan portfolio (in billions of EUR) 1 | ||
| Amount outstanding and undrawn | 262 | 258 |
| Amount outstanding | 207 | 203 |
| Loan portfolio breakdown by business unit (as a % of the outstanding portfolio) | ||
| Belgium | 64.5% | 64.7% |
| Czech Republic | 19.4% | 19.3% |
| International Markets | 15.6% | 15.4% |
| Group Centre 2 | 0.5% | 0.6% |
| Loan portfolio breakdown by counterparty sector (as a % of the outstanding portfolio) | ||
| Private individuals | 40.9% | 40.8% |
| Finance and insurance | 5.8% | 6.0% |
| Governments | 2.8% | 2.7% |
| Corporates | 50.6% | 50.5% |
| Services | 10.7% | 10.5% |
| Distribution | 8.3% | 8.3% |
| Real estate | 6.9% | 6.9% |
| Building & construction | 4.7% | 4.5% |
| Agriculture, farming, fishing | 2.8% | 2.9% |
| Automotive | 2.6% | 2.6% |
| Electricity | 1.9% | 1.8% |
| Food Producers | 1.8% | 1.8% |
| Metals | 1.5% | 1.6% |
| Chemicals | 1.3% | 1.5% |
| Machinery & Heavy equipment | 1.0% | 1.0% |
| Oil, gas & other fuels | 0.8% | 0.9% |
| Shipping | 0.8% | 0.8% |
| Hotels, bars & restaurants | 0.8% | 0.8% |
| Electrotechnics | 0.6% | 0.6% |
| Beverages | 0.5% | 0.4% |
| Timber & wooden furniture | 0.5% | 0.5% |
| Other 3 | 3.2% | 3.3% |
| Loan portfolio breakdown by region (as a % of the outstanding portfolio) | ||
| Belgium | 54.9% | 54.8% |
| Czech Republic | 18.6% | 18.4% |
| Slovakia | 6.1% | 6.3% |
| Hungary | 4.2% | 4.1% |
| Bulgaria | 5.3% | 5.1% |
| Rest of Western Europe | 7.7% | 7.6% |
| Rest of Central and Eastern Europe | 0.2% | 0.2% |
| North America | 1.1% | 1.4% |
| Asia | 0.9% | 0.9% |
| Other | 1.1% | 1.1% |
| Loan portfolio breakdown by counterparty (as % of the outstanding portfolio) | ||
| Retail | 40.9% | 40.8% |
| of which: mortgages | 37.0% | 37.1% |
| of which: consumer finance | 3.8% | 3.7% |
| SME | 22.2% | 21.8% |
| Corporate | 36.9% | 37.4% |
| 30-09-2024 | 31-12-2023 | |
|---|---|---|
| Loan portfolio breakdown by IFRS 9 ECL stage (as % of the outstanding portfolio) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 84.6% | 80.1% |
| of which: PD 1 - 4 | 64.2% | 64.5% |
| of which: PD 5 - 9 including unrated | 20.5% | 15.5% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 4 | 13.3% | 17.9% |
| of which: PD 1 - 4 | 2.7% | 5.1% |
| of which: PD 5 - 9 including unrated | 10.6% | 12.7% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 4 | 2.1% | 2.1% |
| of which: PD 10 impaired loans | 1.0% | 1.1% |
| of which: more than 90 days past due (PD 11+12) | 1.1% | 1.0% |
| Impaired loan portfolio (in millions of EUR) | ||
| Impaired loans (PD10 + 11 + 12) | 4 292 | 4 221 |
| of which: more than 90 days past due | 2 241 | 2 051 |
| Impaired loans ratio (%) | ||
| Belgium | 2.1% | 2.0% |
| Czech Republic | 1.4% | 1.4% |
| International Markets | 1.7% | 1.8% |
| Group Centre 2 | 38.3% | 36.2% |
| Total | 2.1% | 2.1% |
| of which: more than 90 days past due | 1.1% | 1.0% |
| Loan loss impairment (in millions of EUR) | ||
| Loan loss Impairment for Stage 1 portfolio | 166 | 168 |
| Loan loss Impairment for Stage 2 portfolio | 417 | 502 |
| Loan loss Impairment for Stage 3 portfolio | 1 976 | 1 888 |
| of which: more than 90 days past due | 1 464 | 1 459 |
| Cover ratio of impaired loans (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans | 46.0% | 44.7% |
| of which: more than 90 days past due | 65.3% | 71.2% |
| Cover ratio of impaired loans, mortgage loans excluded (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans, mortgage loans excluded | 48.7% | 47.4% |
| of which: more than 90 days past due | 67.7% | 74.2% |
| Credit cost ratio (%) | ||
| Belgium | 0.20% | 0.06% |
| Czech Republic | -0.07% | -0.18% |
| International Markets | -0.10% | -0.06% |
| Slovakia | -0.15% | -0.07% |
| Hungary | -0.38% | -0.14% |
| Bulgaria | 0.16% | 0.00% |
| Group Centre | 0.18% | 0.07% |
| Total | 0.10% | 0.00% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured
in Gross Carrying Amounts 2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group, activities in wind-down (e.g. ex-Antwerp Diamond Bank). The presence of the residual portfolios of the activities in wind-down explains the high share of impaired loans 3 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
4 Purchased or originated credit impaired assets
As of 2022, a collective shift to stage 2 has been applied for the stage 1 portfolios that are indirectly exposed to military conflicts and vulnerable to the geopolitical and macroeconomic uncertainties (for more information see note 4.2.1).
The decrease of the stage 2 ratio is mainly caused by a revised staging methodology (change from indicator based on 12 months probability of default to lifetime, for more information see note 1.2) and for the remainder by a shift for KBC Commercial Finance exposure where the relative change in credit risk has been revisited based on the very low historical credit losses in this portfolio and the very short maturities. Both movements were introduced in 1Q 2024 to better reflect the underlying credit risk since origination.
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2023 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
| Loan portfolio per Business Unit 30-09-2024, in millions of EUR |
Business Unit Belgium1 Business Unit Czech Republic |
Business Unit International Markets | Business Unit Group Centre2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 133 787 | 40 222 | 32 257 | 997 | ||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | ||||||||
| retail | 46 868 | 35% | 22 948 | 57% | 14 857 | 46% | 0 | 0% | ||||
| o/w mortgages | 45 160 | 34% | 20 202 | 50% | 11 378 | 35% | 0 | 0% | ||||
| o/w consumer finance | 1 707 | 1% | 2 746 | 7% | 3 479 | 11% | 0 | 0% | ||||
| SME | 36 084 | 27% | 5 850 | 15% | 4 109 | 13% | 0 | 0% | ||||
| corporate | 50 835 | 38% | 11 424 | 28% | 13 291 | 41% | 997 | 100% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | ||||
| total | 45 160 | 34% | 54% | 20 202 | 50% | 50% | 11 378 | 35% | 57% | 0 | 0% | 0% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | - | 73 | 0% | 38% | 0 | 0% | - |
| o/w ind. LTV > 100% | 391 | 0% | - | 14 | 0% | - | 69 | 0% | - | 0 | 0% | - |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | ||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 98 129 | 73% | 23 308 | 58% | 16 650 | 52% | 580 | 58% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 29 093 | 22% | 14 990 | 37% | 13 858 | 43% | 35 | 4% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 3 462 | 3% | 1 375 | 3% | 1 108 | 3% | 0 | 0% | ||||
| impaired loans (PD 10 - 12) | 2 831 | 2% | 547 | 1% | 532 | 2% | 382 | 38% | ||||
| unrated | 272 | 0% | 2 | 0% | 109 | 0% | 0 | 0% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 831 | 1 140 | 40% | 547 | 251 | 46% | 532 | 253 | 47% | 382 | 332 | 87% |
| o/w PD 10 impaired loans | 1 500 | 350 | 23% | 245 | 72 | 30% | 245 | 67 | 28% | 61 | 22 | 36% |
| o/w more than 90 days past due (PD 11+12 | 1 331 | 790 | 59% | 303 | 179 | 59% | 287 | 185 | 65% | 321 | 310 | 97% |
| all impairments (stage 1+2+3) | 1 436 | 397 | 395 | 332 | ||||||||
| o/w stage 1+2 impairments (incl. POCI) | 296 | 145 | 142 | 1 | ||||||||
| o/w stage 3 impairments (incl. POCI) | 1 140 | 251 | 253 | 332 | ||||||||
| 2023 Credit cost ratio (CCR)3 | 0.06% | -0.18% | -0.06% | 0.07% | ||||||||
| 2024 Credit cost ratio (CCR)3 - YTD |
0.20% | -0.07% | -0.10% | 0.18% |
1 Business Unit Belgium = KBC Bank (all retail and corporate credit lending activities including the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium, KBC Immolease, KBC Commercial Finance
2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank)
3 CCR at country level in local currency
| 30-09-2024, in millions of EUR | Slovakia | Hungary | Bulgaria | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 12 295 | 8 661 | 11 301 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| retail | 7 211 | 59% | 2 969 | 34% | 4 677 | 41% | |||
| o/w mortgages | 6 664 | 54% | 1 979 | 23% | 2 735 | 24% | |||
| o/w consumer finance | 547 | 4% | 990 | 11% | 1 942 | 17% | |||
| SME | 1 268 | 10% | 102 | 1% | 2 738 | 24% | |||
| corporate | 3 816 | 31% | 5 589 | 65% | 3 886 | 34% | |||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | |||
| total | 6 664 | 54% | 61% | 1 979 | 23% | 42% | 2 735 | 24% | 60% |
| o/w FX mortgages | 0 | 0% | - | 1 | 0% | 46% | 73 | 1% | 38% |
| o/w ind. LTV > 100% | 37 | 0% | - | 18 | 0% | 14 | 0% | - | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 8 124 | 66% | 4 525 | 52% | 4 001 | 35% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 3 412 | 28% | 3 890 | 45% | 6 556 | 58% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 547 | 4% | 140 | 2% | 421 | 4% | |||
| impaired loans (PD 10 - 12) | 183 | 1% | 102 | 1% | 247 | 2% | |||
| unrated | 29 | 0% | 4 | 0% | 76 | 1% | |||
| Overall risk indicators | stage 3 imp. % cover |
stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 183 | 95 | 52% | 102 | 33 | 33% | 247 | 125 | 50% |
| o/w PD 10 impaired loans | 71 | 19 | 27% | 75 | 18 | 24% | 99 | 31 | 31% |
| o/w more than 90 days past due (PD 11+12) | 112 | 76 | 67% | 27 | 16 | 58% | 148 | 94 | 64% |
| all impairments (stage 1+2+3) | 139 | 72 | 184 | ||||||
| o/w stage 1+2 impairments (incl. POCI) | 44 | 38 | 59 | ||||||
| o/w stage 3 impairments (incl. POCI) | 95 | 33 | 125 | ||||||
| 2023 Credit cost ratio (CCR)1 | -0.07% | -0.14% | 0.00% | ||||||
| 2024 Credit cost ratio (CCR)1 - YTD |
-0.15% | -0.38% | 0.16% |
1 CCR at country level in local currency
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD. This regulation entered gradually into force as of 1 January 2014.
KBC makes use of the IFRS 9 transitional measures (applied from the second quarter of 2020). These transitional measures make it possible to add back a portion of the increased impairment charges to common equity capital (CET1), during a transitional period until 31 December 2024.
Based on CRR/CRD, profit can be included in CET1 capital only after the profit appropriation decision by the final decision body, for KBC Group it is the General Meeting. ECB can allow to include interim or annual profit in CET1 capital before the decision by the General Meeting. In that case, the foreseeable dividend should be deducted from the profit that is included in CET1. Considering that our Dividend Policy of "at least 50%" does not include a maximum, KBC Group no longer requests ECB approval to include interim or annual profit in CET1 capital before the decision by the General Meeting.
As such, the annual profit of 2024 and the dividend re. 2024 will be recognised in the official (transitional) CET1 of the 1st quarter 2025, which is reported after the General Meeting. The 2024 interim profit is included in the fully loaded CET1 (taking into account 50% pay-out in line with our Dividend Policy).
The general rule under CRR/CRD for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). As of the fourth quarter of 2020, the revised CRR/CRD requires the use of the equity method, unless the competent authority allows institutions to apply a different method. KBC Group has received ECB approval to continue to use the historical carrying value for risk weighting (370%), after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRR/CRD, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRR/CDR rules, used for approximately 74% of the weighted credit risks. The remaining weighted credit risks (ca. 26%) are calculated according to the Standardised approach.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.82% (fully loaded, Danish Compromise which includes the CRR/CRD minimum requirement (4.50%), the Pillar 2 Requirement (1.05% P2R, taking into account CRD V Art 104a(4)) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% buffer for other systemically important banks, 0.14% Systemic Risk Buffer and 1.14% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.25%. In line with CRD V Art. 104a(4), ECB allows banks to satisfy the P2R (1.86%) with additional tier-1 instruments (up to 1.5/8) and tier-2 instruments (up to 2/8) based on the same relative weights as allowed for meeting the 8% Pillar 1 Requirement.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The next table provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) |
30-09-2024 | 31-12-2023 | ||
|---|---|---|---|---|
| (consolidated, under CRR, Danish compromise method) | Fully loaded | Actuals | Fully loaded | Actuals |
| CET1 Pillar 1 minimum | 4.50% | 4.50% | 4.50% | 4.50% |
| Pillar 2 requirement to be satisfied with CET1 | 1.05% | 1.05% | 1.05% | 1.05% |
| Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% |
| Buffer for systemically important institutions (O-SII) | 1.50% | 1.50% | 1.50% | 1.50% |
| Systemic Risk Buffer (SRyB) | 0.14% | 0.14% | 0.14% | 0.21% |
| Entity-specific countercyclical buffer | 1.14% | 0.86% | 1.24% | 0.67% |
| Overall Capital Requirement (OCR) - with P2R split, CRD Art. 104a(4) | 10.82% | 10.54% | 10.92% | 10.43% |
| CET1 used to satisfy shortfall in AT1 bucket | 0.25% | 0.25% | 0.30% | 0.30% |
| CET1 used to satisfy shortfall in T2 bucket | 0.00% | 0.00% | 0.45% | 0.36% |
| CET1 requirement for MDA | 11.08% | 10.79% | 11.68% | 11.09% |
| CET1 capital | 17 742 | 16 985 | 17 236 | 15 639 |
| CET1 buffer (= buffer compared to MDA) | 4 802 | 4 376 | 4 036 | 3 105 |
Note: The fully loaded T2 capital excludes the T2 instruments grandfathered under CRR2; these T2 instruments are included in the actual (transitional) T2 capital for the period of grandfathering, in line with CRR2 and the COREP 3.0 reporting framework.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios | denominator | |||
|---|---|---|---|---|
| (in millions of EUR) | numerator | (total | ||
| 30-09-2024 | (common equity) |
weighted risk volume) |
ratio (%) | |
| Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 17 742 | 116 817 | 15.19% |
| Deduction Method | Fully loaded | 17 081 | 112 204 | 15.22% |
| Financial Conglomerates Directive | Fully loaded | 19 369 | 135 257 | 14.32% |
| Danish Compromise | Transitional | 16 985 | 116 822 | 14.54% |
| Deduction Method | Transitional | 16 248 | 112 018 | 14.51% |
| Financial Conglomerates Directive | Transitional | 18 845 | 135 262 | 13.93% |
KBC's fully loaded CET1 ratio of 15.19% at the end of September 2024 represents a solid capital buffer of 4.11% compared with the Maximum Distributable Amount (MDA) of 11.08%.
After having received ECB approval, the Board of Directors decided to distribute 1.3 billion euros in the form of a share buyback, which has started on 11 August 2023 and ended by 31 July 2024. As such, 1.3 billion euros is deducted from the fully loaded and transitional Common equity ratio as of 3Q 2023.
In line with our Dividend Policy, we will pay out an interim dividend of 1 euro per share on 14 November 2024 as an advance on the total dividend for financial year 2024 (already taken into account in the Common equity ratio).
The EBA Monitoring report on AT1, Tier 2 and TLAC / MREL eligible liabilities instruments (27 June 2024) recommends to use the carrying amounts (including accrued interest and hedge adjustments) instead of nominal amounts for own funds calculation. KBC has applied this EBA recommendation as at 30-09-2024. Implementation of this approach increases the volatility in the Tier 2 capital: as at 30-09-2024 it has a 17 million euros positive impact on Tier 2 capital at KBC Group level .
Moving towards the Basel IV era and applying a static balance sheet (1H 2024) and all other parameters ceteris paribus, without mitigating actions, KBC projects:
resulting in a fully loaded impact of +8.5 billion euros in risk-weighted assets (+8.0 billion euros previously).
| 30-09-2024 | 30-09-2024 | 31-12-2023 | 31-12-2023 | |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital (after profit appropriation) | 22 947 | 22 124 | 21 260 | 19 768 |
| Tier-1 capital | 19 606 | 18 849 | 18 986 | 17 389 |
| Common equity | 17 742 | 16 985 | 17 236 | 15 639 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 20 503 | 19 023 | 21 181 | 18 209 |
| Intangible fixed assets, incl deferred tax impact (-) | - 668 | - 668 | - 712 | - 712 |
| Goodwill on consolidation, incl deferred tax impact (-) | - 1 058 | - 1 058 | - 1 070 | - 1 070 |
| Minority interests | 0 | 0 | 0 | 0 |
| Hedging reserve (cash flow hedges) (-) | 480 | 480 | 579 | 579 |
| Valuation diff. in financial liabilities at fair value - own credit risk (-) | - 26 | - 26 | - 29 | - 29 |
| Value adjustment due to the requirements for prudent valuation (-) | - 36 | - 36 | - 24 | - 24 |
| Dividend payout (-) | - 692 | 0 | - 1 287 | 0 |
| Share buyback (part not yet executed) (-) | 0 | 0 | - 803 | - 803 |
| Coupon of AT1 instruments (-) | - 10 | - 10 | - 26 | - 26 |
| Deduction re. financing provided to shareholders (-) | - 15 | - 15 | - 56 | - 56 |
| Deduction re. Irrevocable payment commitments (-) | - 90 | - 90 | - 90 | - 90 |
| Deduction re NPL backstops (-) | - 249 | - 249 | - 204 | - 204 |
| Deduction re pension plan assets (-) | - 193 | - 193 | - 121 | - 121 |
| IRB provision shortfall (-) | - 149 | - 125 | - 4 | 0 |
| Deferred tax assets on losses carried forward (-) | - 56 | - 56 | - 98 | - 98 |
| Transitional adjustments to CET1 | 0 | 7 | 0 | 84 |
| Limit on deferred tax assets from timing differences relying on future profitability and significant participations in financial sector entities (-) |
0 | 0 | 0 | 0 |
| Additional going concern capital | 1 864 | 1 864 | 1 750 | 1 750 |
| CRR compliant AT1 instruments | 1 864 | 1 864 | 1 750 | 1 750 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 3 342 | 3 275 | 2 273 | 2 379 |
| IRB provision excess (+) | 233 | 165 | 277 | 265 |
| Transitional adjustments to T2 | 0 | 0 | 0 | - 60 |
| Subordinated liabilities | 3 109 | 3 110 | 1 997 | 2 174 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 | 0 | 0 |
| Total weighted risk volume | 116 817 | 116 822 | 113 038 | 113 029 |
| Banking | 107 029 | 107 034 | 103 201 | 103 192 |
| Insurance | 9 133 | 9 133 | 9 133 | 9 133 |
| Holding activities | 679 | 679 | 710 | 710 |
| Elimination of intercompany transactions | - 24 | - 24 | - 6 | - 6 |
| Solvency ratios | ||||
| Common equity ratio | 15.19% | 14.54% | 15.25% | 13.84% |
| Tier-1 ratio | 16.78% | 16.13% | 16.80% | 15.38% |
| Total capital ratio | 19.64% | 18.94% | 18.81% | 17.49% |
Note:
• For the composition of the banking RWA, see section 'Solvency banking and insurance activities separately' further in this report.
| Leverage ratio KBC Group | 30-09-2024 | 30-09-2024 | 31-12-2023 | 31-12-2023 |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Tier-1 capital | 19 606 | 18 849 | 18 986 | 17 389 |
| Total exposures | 342 034 | 342 043 | 333 791 | 333 894 |
| Total Assets | 353 261 | 353 261 | 346 921 | 346 921 |
| Deconsolidation KBC Insurance | -33 034 | -33 034 | -30 980 | -30 980 |
| Transitional adjustment | 0 | 8 | 0 | 103 |
| Adjustment for derivatives | 175 | 175 | -1 341 | -1 341 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 399 | -2 399 | -2 286 | -2 286 |
| Adjustment for securities financing transaction exposures | 1 703 | 1 703 | 1 357 | 1 357 |
| Central Bank exposure | 0 | 0 | 0 | 0 |
| Off-balance sheet exposures | 22 328 | 22 328 | 20 119 | 20 119 |
| Leverage ratio | 5.73% | 5.51% | 5.69% | 5.21% |
At the end of September 2024, the fully loaded leverage ratio increased compared to December 2023, due to higher Tier-1 capital partly offset by higher leverage ratio exposure chiefly as a result of higher total assets (for more information see balance sheet in the Consolidated financial statements section).
. . .
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRR/CRD) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| Regulatory capital requirements KBC Bank (consolidated) | 30-09-2024 | 30-09-2024 | 31-12-2023 | 31-12-2023 |
|---|---|---|---|---|
| (in millions of EUR) | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital, after profit appropriation | 21 008 | 20 043 | 19 375 | 17 952 |
| Tier-1 capital | 17 681 | 16 784 | 16 924 | 15 573 |
| Common equity | 15 817 | 14 920 | 15 174 | 13 823 |
| Parent shareholders' equity | 17 699 | 16 770 | 17 695 | 15 450 |
| Solvency adjustments | -1 882 | -1 850 | -2 521 | -1 627 |
| Additional going concern capital | 1 864 | 1 864 | 1 750 | 1 750 |
| Tier-2 capital | 3 327 | 3 259 | 2 451 | 2 379 |
| Total weighted risk volume | 107 029 | 107 034 | 103 201 | 103 192 |
| Credit risk | 91 960 | 91 965 | 88 051 | 88 042 |
| Market risk | 2 035 | 2 035 | 2 116 | 2 116 |
| Operation risk | 13 034 | 13 034 | 13 034 | 13 034 |
| Common equity ratio | 14.8% | 13.9% | 14.7% | 13.4% |
| Own Funds | 4 338 | 4 130 |
|---|---|---|
| Tier 1 | 3 837 | 3 629 |
| IFRS Parent shareholders' equity | 3 405 | 3 302 |
| Dividend payout | - 263 | - 233 |
| Deduction intangible assets and goodwill (after tax) | - 204 | - 198 |
| Valuation differences (after tax) | 676 | 597 |
| Volatility adjustment | 166 | 137 |
| Other | 56 | 25 |
| Tier 2 | 501 | 501 |
| Subordinated liabilities | 501 | 501 |
| Solvency Capital Requirement (SCR) | 2 206 | 2 005 |
| Market risk | 1 569 | 1 434 |
| Non-life | 841 | 786 |
| Life | 1 210 | 1 131 |
| Health | 316 | 278 |
| Counterparty | 135 | 124 |
| Diversification | -1 403 | -1 293 |
| Other | - 464 | - 455 |
| Solvency II ratio | 197% | 206% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
In June 2024, the SRB formally communicated to KBC binding MREL targets (under BRRD2), expressed as a percentage of Risk Weighted Assets (RWA) and Leverage Ratio Exposure Amount (LRE):
Besides a total MREL amount, BRRD2 also requires KBC to maintain a certain part of MREL in subordinated format (i.e. instruments subordinated to liabilities, excluded from bail-in).
The binding subordinated MREL targets are:
At the end of September 2024, the MREL ratio stands at 31.3% as a % of RWA (versus 30.7% as at the end 2023) and at 10.7% as % of LRE (versus 10.4% as at the end of 2023). The increase of the MREL ratio in % of RWA is driven mainly by the increased common equity due to recognition of retained earnings in 9M 2024 and increased Tier-2 capital, partially offset by increase of total weighted risk volume. The increase of the MREL ratio in % of LRE is driven mainly by the growth in available MREL, which more than offset the increased leverage exposure.
(1) Combined Buffer Requirement (transitional) = Conservation Buffer (2.50%) + O-SII Buffer (1.50%) + Countercyclical Buffer (0.86%) + Systemic Risk Buffer (0.14%) comes on top of the MREL target as a percentage of RWA
Details on our segments or business units are available in the company presentation.
Note: The ECB approved to apply the IFRS9 transitional arrangements from 2Q 2020, as such the difference between fully loaded and the transitional measures are assigned to Group Centre. In other words, the RWA, allocated capital and the ROAC of the different countries remain based on fully loaded.
| KBC Group | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 1 394 | 1 379 | 1 369 | 1 360 | 1 382 |
| Insurance revenues before reinsurance | 740 | 726 | 714 | 683 | 699 |
| Non-life | 631 | 613 | 598 | 584 | 587 |
| Life | 109 | 114 | 116 | 99 | 113 |
| Dividend income | 11 | 26 | 7 | 12 | 10 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
- 42 | 3 | - 55 | - 40 | - 8 |
| Net fee and commission income | 641 | 623 | 614 | 600 | 588 |
| Net other income | 45 | 51 | 58 | 60 | 44 |
| TOTAL INCOME | 2 787 | 2 809 | 2 708 | 2 674 | 2 715 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 1 058 | - 950 | - 1 431 | - 1 085 | - 1 011 |
| Total Opex without bank and insurance tax | - 1 135 | - 1 074 | - 1 063 | - 1 169 | - 1 101 |
| Total bank and insurance tax | - 47 | - 2 | - 518 | - 36 | - 29 |
| Minus: Opex allocated to insurance service expenses | 124 | 126 | 150 | 120 | 119 |
| Insurance service expenses before reinsurance | - 688 | - 590 | - 563 | - 567 | - 540 |
| Of which Insurance commissions paid | - 99 | - 92 | - 89 | - 94 | - 87 |
| Non-life | - 615 | - 514 | - 489 | - 509 | - 485 |
| of which Non-life - Claim related expenses | - 427 | - 331 | - 293 | - 328 | - 308 |
| Life | - 72 | - 76 | - 73 | - 58 | - 55 |
| Net result from reinsurance contracts held | 28 | - 24 | - 18 | - 16 | - 22 |
| Impairment | - 69 | - 85 | - 16 | - 170 | - 63 |
| on FA at amortised cost and at FVOCI | - 61 | - 72 | - 16 | 5 | - 36 |
| on goodwill | 0 | 0 | 0 | - 109 | 0 |
| other Share in results of associated companies and joint ventures |
- 7 78 |
- 13 2 |
0 0 |
- 66 0 |
- 27 0 |
| RESULT BEFORE TAX | 1 079 | 1 162 | 680 | 836 | 1 079 |
| Income tax expense | - 211 | - 237 | - 175 | - 159 | - 203 |
| RESULT AFTER TAX | 868 | 925 | 506 | 677 | 877 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 868 | 925 | 506 | 677 | 877 |
| Banking | 774 | 774 | 356 | 566 | 722 |
| Insurance | 104 | 139 | 133 | 108 | 134 |
| Holding activities Breakdown Loans and deposits |
- 9 | 13 | 16 | 3 | 20 |
| Total customer loans excluding reverse repos (end of period) | 188 623 | 187 502 | 183 722 | 183 613 | 181 821 |
| of which Mortgage loans (end of period) | 76 926 | 76 236 | 75 311 | 75 482 | 75 105 |
| Customer deposits and debt certificates excl. repos (end of period) Insurance related liabilities (including Inv. Contracts) |
263 071 | 271 610 | 263 700 | 259 491 | 260 383 |
| Life insurance | 29 020 | 28 272 | 27 938 | 27 323 | 25 754 |
| Liabilities under investment contracts (IFRS 9) | 15 193 | 14 780 | 14 319 | 13 461 | 12 655 |
| Insurance contract liabilities (IFRS 17) | 13 827 | 13 492 | 13 618 | 13 862 | 13 099 |
| Non-life insurance | 3 186 | 3 029 | 2 984 | 2 922 | 2 821 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 116 817 | 115 635 | 114 101 | 113 038 | 115 255 |
| Required capital, insurance (end of period) | 2 206 | 2 153 | 2 055 | 2 005 | 2 034 |
| Allocated capital (end of period) | 13 965 | 13 783 | 13 517 | 13 788 | 14 068 |
| Return on allocated capital (ROAC, YTD) | 22% | 21% | 15% | 25% | 27% |
| Cost/income ratio without banking and insurance tax (YTD) | 43% | 42% | 43% | 43% | 41% |
| Combined ratio, non-life insurance (YTD) | 89% | 87% | 85% | 87% | 85% |
| Net interest margin, banking (QTD) | 2.09% | 2.10% | 2.08% | 1.99% | 2.04% |
| Business unit Belgium | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 828 | 831 | 809 | 809 | 812 |
| Insurance revenues before reinsurance | 447 | 445 | 443 | 416 | 430 |
| Non-life | 379 | 371 | 365 | 355 | 354 |
| Life | 68 | 74 | 78 | 61 | 76 |
| Dividend income | 7 | 24 | 7 | 11 | 7 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
- 65 | - 64 | - 101 | - 86 | - 47 |
| Net fee and commission income | 419 | 409 | 409 | 393 | 384 |
| Net other income | 49 | 46 | 54 | 57 | 43 |
| TOTAL INCOME | 1 686 | 1 692 | 1 621 | 1 600 | 1 628 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 563 | - 503 | - 841 | - 583 | - 556 |
| Total Opex without bank and insurance tax | - 634 | - 609 | - 606 | - 643 | - 625 |
| Total bank and insurance tax | 0 | 32 | - 317 | - 8 | 0 |
| Minus: Opex allocated to insurance service expenses | 71 | 73 | 82 | 68 | 70 |
| Insurance service expenses before reinsurance | - 360 | - 363 | - 340 | - 341 | - 327 |
| Of which Insurance commissions paid | - 62 | - 59 | - 57 | - 57 | - 58 |
| Amortised insurance acquisition commissions | - 58 | - 55 | - 53 | - 53 | - 54 |
| Non-acquisition commissions | - 4 | - 5 | - 5 | - 4 | - 4 |
| Non-life | - 311 | - 311 | - 289 | - 305 | - 292 |
| of which Non-life - Claim related expenses | - 209 | - 210 | - 191 | - 211 | - 194 |
| Life | - 49 | - 53 | - 52 | - 36 | - 35 |
| Net result from reinsurance contracts held | - 20 | - 9 | - 24 | - 19 | - 7 |
| Impairment | - 42 | - 123 | - 37 | - 28 | - 58 |
| on FA at amortised cost and at FVOCI | - 40 | - 122 | - 37 | - 10 | - 42 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 2 | - 1 | 0 | - 18 | - 16 |
| Share in results of associated companies and joint ventures | 78 | 1 | 0 | 1 | 0 |
| RESULT BEFORE TAX | 779 | 694 | 380 | 630 | 682 |
| Income tax expense | - 182 | - 176 | - 137 | - 156 | - 164 |
| RESULT AFTER TAX | 598 | 518 | 242 | 474 | 517 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 598 | 519 | 243 | 474 | 517 |
| Banking | 503 | 407 | 143 | 392 | 414 |
| Insurance | 95 | 111 | 99 | 82 | 103 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 121 832 | 121 459 | 119 331 | 119 168 | 118 189 |
| of which Mortgage loans (end of period) | 45 970 | 45 613 | 45 397 | 45 394 | 45 147 |
| Customer deposits and debt certificates excl. repos (end of period) | 157 465 | 165 002 | 157 665 | 154 238 | 155 868 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 27 266 | 26 530 | 26 213 | 25 572 | 24 070 |
| Liabilities under investment contracts (IFRS 9) | 15 193 | 14 780 | 14 319 | 13 461 | 12 655 |
| Insurance contract liabilities (IFRS 17) | 12 073 | 11 750 | 11 894 | 12 111 | 11 415 |
| Non-life insurance | 2 361 | 2 298 | 2 282 | 2 204 | 2 139 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 65 297 | 63 753 | 63 063 | 62 030 | 64 014 |
| Required capital, insurance (end of period) | 1 906 | 1 801 | 1 785 | 1 694 | 1 702 |
| Allocated capital (end of period) | 9 036 | 8 763 | 8 672 | 8 728 | 8 961 |
| Return on allocated capital (ROAC, YTD) | 21% | 18% | 11% | 22% | 23% |
| Cost/income ratio without banking and insurance tax (YTD) | 41% | 40% | 41% | 41% | 40% |
| Combined ratio, non-life insurance (YTD) | 87% | 86% | 86% | 85% | 83% |
| Net interest margin, banking (QTD) | 1.94% | 1.97% | 1.94% | 1.90% | 1.91% |
| Business unit Czech Republic | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 325 | 323 | 315 | 322 | 316 |
| Insurance revenues before reinsurance | 151 | 144 | 138 | 142 | 143 |
| Non-life | 126 | 119 | 114 | 117 | 119 |
| Life | 25 | 25 | 24 | 25 | 24 |
| Dividend income | 0 | 1 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 11 | 10 | 22 | 13 | 11 |
| Net fee and commission income | 87 | 84 | 84 | 81 | 81 |
| Net other income | 0 | - 1 | 5 | 3 | - 5 |
| TOTAL INCOME | 573 | 561 | 564 | 560 | 546 |
| Operating expenses (excluding Opex allocated to insurance service | - 207 | - 196 | - 229 | - 210 | - 203 |
| ) Total Opex without bank and insurance tax |
- 234 | - 221 | - 220 | - 237 | - 231 |
| Total bank and insurance tax | - 1 | - 3 | - 35 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 29 | 27 | 26 | 27 | 29 |
| Insurance service expenses before reinsurance | - 198 | - 104 | - 99 | - 113 | - 108 |
| Of which Insurance commissions paid | - 20 | - 16 | - 17 | - 21 | - 16 |
| Non-life | - 185 | - 91 | - 86 | - 100 | - 94 |
| of which Non-life - Claim related expenses | - 143 | - 53 | - 49 | - 57 | - 55 |
| Life | - 13 | - 12 | - 13 | - 13 | - 14 |
| Net result from reinsurance contracts held | 60 | - 6 | - 4 | - 2 | - 5 |
| Impairment | - 17 | 41 | - 4 | - 114 | - 3 |
| on FA at amortised cost and at FVOCI | - 17 | 41 | - 4 | 14 | - 4 |
| on goodwill | 0 | 0 | 0 | - 109 | 0 |
| other | 0 | - 1 | 0 | - 19 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | - 1 | 0 |
| RESULT BEFORE TAX | 211 | 297 | 229 | 121 | 228 |
| Income tax expense | - 32 | - 52 | - 33 | - 19 | - 27 |
| RESULT AFTER TAX | 179 | 244 | 197 | 102 | 200 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 179 | 244 | 197 | 102 | 200 |
| Banking | 165 | 213 | 164 | 73 | 172 |
| Insurance | 15 | 31 | 32 | 29 | 28 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 37 756 | 37 422 | 36 262 | 36 470 | 36 530 |
| of which Mortgage loans (end of period) | 19 738 | 19 685 | 19 283 | 19 641 | 19 796 |
| Customer deposits and debt certificates excl. repos (end of period) | 51 867 | 51 939 | 51 435 | 52 642 | 54 569 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 862 | 868 | 891 | 931 | 927 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 862 | 868 | 891 | 931 | 927 |
| Non-life insurance | 422 | 349 | 343 | 357 | 347 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 18 389 | 18 124 | 17 488 | 17 515 | 17 647 |
| Required capital, insurance (end of period) | 166 | 170 | 163 | 165 | 170 |
| Allocated capital (end of period) | 2 174 | 2 149 | 2 073 | 2 152 | 2 171 |
| Return on allocated capital (ROAC, YTD) | 39% | 42% | 38% | 35% | 40% |
| Cost/income ratio without banking and insurance tax (YTD) | 43% | 42% | 42% | 44% | 44% |
| Combined ratio, non-life insurance (YTD) | 87% | 80% | 79% | 84% | 83% |
| Net interest margin, banking (QTD) | 2.40% | 2.42% | 2.39% | 2.29% | 2.26% |
| Business unit International Markets | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 321 | 317 | 324 | 308 | 296 |
| Insurance revenues before reinsurance | 138 | 133 | 130 | 122 | 122 |
| Non-life | 123 | 119 | 116 | 109 | 109 |
| Life | 15 | 15 | 15 | 13 | 14 |
| Dividend income | 1 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
8 | 14 | 26 | 8 | 15 |
| Net fee and commission income | 136 | 131 | 122 | 127 | 124 |
| Net other income | 0 | 9 | 6 | 0 | 5 |
| TOTAL INCOME | 604 | 605 | 608 | 566 | 562 |
| Operating expenses (excluding Opex allocated to insurance service | - 236 | - 215 | - 326 | - 222 | - 218 |
| ) Total Opex without bank and insurance tax |
- 214 | - 207 | - 200 | - 219 | - 209 |
| Total bank and insurance tax | - 46 | - 32 | - 167 | - 28 | - 29 |
| Minus: Opex allocated to insurance service expenses | 25 | 25 | 41 | 26 | 20 |
| Insurance service expenses before reinsurance | - 127 | - 121 | - 125 | - 114 | - 104 |
| Of which Insurance commissions paid | - 17 | - 17 | - 15 | - 16 | - 14 |
| Non-life | - 117 | - 111 | - 116 | - 105 | - 97 |
| of which Non-life - Claim related expenses | - 73 | - 67 | - 55 | - 62 | - 58 |
| Life | - 9 | - 11 | - 9 | - 9 | - 7 |
| Net result from reinsurance contracts held | 6 | - 3 | 0 | - 1 | - 4 |
| Impairment | - 9 | - 3 | 20 | - 24 | - 5 |
| on FA at amortised cost and at FVOCI | - 4 | 9 | 20 | 1 | 7 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 6 | - 11 | 0 | - 25 | - 11 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 239 | 263 | 177 | 206 | 232 |
| Income tax expense | - 34 | - 39 | - 30 | - 27 | - 32 |
| RESULT AFTER TAX | 205 | 224 | 146 | 178 | 200 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 205 | 224 | 146 | 178 | 200 |
| Banking | 187 | 212 | 141 | 171 | 185 |
| Insurance | 18 | 12 | 6 | 7 | 14 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 29 035 | 28 621 | 28 129 | 27 975 | 27 101 |
| of which Mortgage loans (end of period) | 11 218 | 10 937 | 10 631 | 10 447 | 10 162 |
| Customer deposits and debt certificates excl. repos (end of period) | 32 189 | 31 730 | 31 702 | 31 687 | 29 959 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 891 | 875 | 833 | 820 | 757 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 891 | 875 | 833 | 820 | 757 |
| Non-life insurance | 379 | 362 | 345 | 343 | 317 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 22 758 | 23 382 | 23 082 | 22 980 | 22 584 |
| Required capital, insurance (end of period) | 183 | 179 | 171 | 167 | 160 |
| Allocated capital (end of period) | 2 668 | 2 732 | 2 691 | 2 773 | 2 721 |
| Return on allocated capital (ROAC, YTD) | 29% | 27% | 22% | 25% | 25% |
| Cost/income ratio without banking and insurance tax (YTD) | 37% | 36% | 35% | 39% | 38% |
| Combined ratio, non-life insurance (YTD) | 97% | 100% | 102% | 97% | 96% |
| Net interest margin, banking (QTD) | 3.18% | 3.27% | 3.40% | 3.27% | 3.21% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 92% in 9M 2024 & 1H 2024, 88% in 1Q 2024, 94% in 2023 and 92% in 9M 2023.
| Slovakia | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 69 | 69 | 67 | 65 | 60 |
| Insurance revenues before reinsurance | 28 | 27 | 26 | 25 | 25 |
| Non-life | 22 | 22 | 21 | 20 | 21 |
| Life | 5 | 5 | 5 | 4 | 4 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 1 | 2 | 3 | - 6 | 3 |
| Net fee and commission income | 21 | 21 | 21 | 22 | 21 |
| Net other income | 0 | 5 | 3 | 2 | 5 |
| TOTAL INCOME | 116 | 125 | 121 | 108 | 113 |
| Operating expenses (excluding Opex allocated to insurance service ) |
- 69 | - 66 | - 64 | - 59 | - 57 |
| Total Opex without bank and insurance tax | - 66 | - 64 | - 62 | - 66 | - 63 |
| Total bank and insurance tax | - 9 | - 8 | - 9 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 7 | 7 | 7 | 7 | 6 |
| Insurance service expenses before reinsurance | - 28 | - 32 | - 24 | - 30 | - 22 |
| Of which Insurance commissions paid | - 3 | - 3 | - 3 | - 4 | - 2 |
| Non-life | - 24 | - 28 | - 21 | - 27 | - 20 |
| of which Non-life - Claim related expenses | - 16 | - 21 | - 13 | - 18 | - 13 |
| Life | - 4 | - 4 | - 3 | - 3 | - 2 |
| Net result from reinsurance contracts held | 3 | 0 | - 1 | 4 | - 1 |
| Impairment | - 3 | 6 | 11 | 0 | - 2 |
| on FA at amortised cost and at FVOCI | - 3 | 6 | 11 | 2 | - 2 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | 0 | 0 | - 2 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 20 | 33 | 43 | 24 | 32 |
| Income tax expense | - 4 | - 7 | - 9 | - 6 | - 7 |
| RESULT AFTER TAX | 16 | 27 | 34 | 18 | 25 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 16 | 27 | 34 | 18 | 25 |
| Banking | 13 | 30 | 33 | 18 | 23 |
| Insurance | 2 | - 4 | 1 | 0 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 11 672 | 11 667 | 11 625 | 11 589 | 11 433 |
| of which Mortgage loans (end of period) | 6 622 | 6 578 | 6 504 | 6 451 | 6 373 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 228 | 8 961 | 8 830 | 8 836 | 8 491 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 173 | 173 | 165 | 168 | 154 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 173 | 173 | 165 | 168 | 154 |
| Non-life insurance | 72 | 68 | 59 | 58 | 51 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 7 768 | 7 827 | 7 817 | 7 911 | 6 451 |
| Required capital, insurance (end of period) | 32 | 32 | 30 | 29 | 28 |
| Allocated capital (end of period) | 880 | 886 | 884 | 926 | 760 |
| Return on allocated capital (ROAC, YTD) | 11% | 14% | 15% | 13% | 15% |
| Cost/income ratio without banking and insurance tax (YTD) | 56% | 54% | 54% | 58% | 56% |
| Combined ratio, non-life insurance (YTD) | 112% | 120% | 107% | 101% | 97% |
| Hungary | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 143 | 138 | 149 | 140 | 132 |
| Insurance revenues before reinsurance | 52 | 50 | 52 | 48 | 48 |
| Non-life | 47 | 45 | 47 | 43 | 43 |
| Life | 5 | 5 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 9 | 12 | 22 | 14 | 11 |
| Net fee and commission income | 75 | 71 | 63 | 69 | 66 |
| Net other income | - 2 | 3 | 3 | - 3 | - 2 |
| TOTAL INCOME Operating expenses (excluding Opex allocated to insurance service |
277 | 275 | 289 | 267 | 256 |
| ) | - 103 | - 87 | - 179 | - 93 | - 93 |
| Total Opex without bank and insurance tax | - 75 | - 72 | - 69 | - 75 | - 71 |
| Total bank and insurance tax | - 37 | - 24 | - 137 | - 28 | - 29 |
| Minus: Opex allocated to insurance service expenses | 9 | 9 | 27 | 10 | 7 |
| Insurance service expenses before reinsurance | - 53 | - 44 | - 66 | - 44 | - 45 |
| Of which Insurance commissions paid | - 3 | - 4 | - 2 | - 3 | - 3 |
| Non-life | - 50 | - 40 | - 63 | - 41 | - 42 |
| of which Non-life - Claim related expenses | - 31 | - 21 | - 25 | - 22 | - 24 |
| Life | - 3 | - 4 | - 3 | - 3 | - 3 |
| Net result from reinsurance contracts held | 6 | - 2 | 5 | - 1 | - 1 |
| Impairment | 1 | - 3 | 11 | - 21 | - 4 |
| on FA at amortised cost and at FVOCI | 6 | 8 | 10 | - 1 | 6 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 5 | - 11 | 0 | - 20 | - 10 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 127 | 139 | 60 | 108 | 113 |
| Income tax expense | - 17 | - 18 | - 10 | - 14 | - 16 |
| RESULT AFTER TAX | 110 | 121 | 50 | 94 | 96 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 110 | 121 | 50 | 94 | 96 |
| Banking | 105 | 115 | 58 | 91 | 94 |
| Insurance | 5 | 6 | - 8 | 3 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 6 860 | 6 773 | 6 640 | 6 764 | 6 445 |
| of which Mortgage loans (end of period) | 1 980 | 1 903 | 1 815 | 1 818 | 1 754 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 587 | 9 536 | 9 577 | 9 610 | 8 881 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 316 | 315 | 305 | 299 | 285 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 316 | 315 | 305 | 299 | 285 |
| Non-life insurance | 125 | 119 | 117 | 114 | 104 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 6 491 | 6 777 | 6 641 | 6 646 | 8 240 |
| Required capital, insurance (end of period) | 62 | 62 | 58 | 59 | 54 |
| Allocated capital (end of period) | 771 | 802 | 784 | 812 | 989 |
| Return on allocated capital (ROAC, YTD) | 48% | 43% | 25% | 30% | 26% |
| Cost/income ratio without banking and insurance tax (YTD) | 27% | 26% | 25% | 28% | 27% |
| Combined ratio, non-life insurance (YTD) | 104% | 109% | 124% | 105% | 108% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 92% in 9M 2024, 90% in 1H 2024, 89% in 1Q 2024, 97% in 2023 & 9M 2023.
| Bulgaria | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 110 | 110 | 107 | 103 | 104 |
| Insurance revenues before reinsurance | 59 | 57 | 53 | 50 | 50 |
| Non-life | 54 | 52 | 48 | 45 | 45 |
| Life | 5 | 5 | 5 | 5 | 4 |
| Dividend income | 1 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 1 | - 1 | 0 | 0 | 1 |
| Net fee and commission income | 40 | 38 | 37 | 37 | 37 |
| Net other income | 2 | 1 | 0 | 1 | 1 |
| TOTAL INCOME | 211 | 205 | 197 | 192 | 193 |
| Operating expenses (excluding Opex allocated to insurance service ) |
- 64 | - 62 | - 83 | - 70 | - 68 |
| Total Opex without bank and insurance tax | - 72 | - 71 | - 70 | - 78 | - 75 |
| Total bank and insurance tax | 0 | 0 | - 21 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 9 | 9 | 8 | 9 | 7 |
| Insurance service expenses before reinsurance | - 45 | - 45 | - 35 | - 40 | - 37 |
| Of which Insurance commissions paid | - 10 | - 10 | - 9 | - 9 | - 8 |
| Non-life | - 43 | - 42 | - 32 | - 38 | - 35 |
| of which Non-life - Claim related expenses | - 26 | - 26 | - 17 | - 22 | - 21 |
| Life | - 3 | - 3 | - 3 | - 3 | - 2 |
| Net result from reinsurance contracts held | - 2 | - 1 | - 4 | - 4 | - 3 |
| Impairment | - 7 | - 5 | - 2 | - 3 | 2 |
| on FA at amortised cost and at FVOCI | - 7 | - 5 | - 2 | - 1 | 3 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 1 | 0 | 0 | - 3 | - 1 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 92 | 91 | 74 | 74 | 88 |
| Income tax expense | - 12 | - 14 | - 11 | - 7 | - 9 |
| RESULT AFTER TAX | 80 | 76 | 63 | 67 | 79 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 80 | 76 | 63 | 67 | 79 |
| Banking | 69 | 67 | 50 | 62 | 69 |
| Insurance | 11 | 9 | 13 | 4 | 10 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 10 503 | 10 182 | 9 864 | 9 623 | 9 223 |
| of which Mortgage loans (end of period) | 2 616 | 2 456 | 2 312 | 2 178 | 2 035 |
| Customer deposits and debt certificates excl. repos (end of period) | 13 373 | 13 234 | 13 295 | 13 241 | 12 588 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 402 | 387 | 364 | 353 | 319 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 402 | 387 | 364 | 353 | 319 |
| Non-life insurance | 182 | 176 | 169 | 171 | 162 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 8 499 | 8 778 | 8 623 | 8 423 | 7 892 |
| Required capital, insurance (end of period) | 89 | 85 | 83 | 80 | 77 |
| Allocated capital (end of period) | 1 017 | 1 044 | 1 024 | 1 035 | 972 |
| Return on allocated capital (ROAC, YTD) | 29% | 27% | 25% | 30% | 31% |
| Cost/income ratio without banking and insurance tax (YTD) | 40% | 40% | 40% | 42% | 41% |
| Combined ratio, non-life insurance (YTD) | 85% | 83% | 79% | 87% | 83% |
| Business unit Group Centre | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2024 | 2Q 2024 | 1Q 2024 | 4Q 2023 | 3Q 2023 |
| Breakdown P&L | |||||
| Net interest income | - 80 | - 92 | - 79 | - 79 | - 41 |
| Insurance revenues before reinsurance | 4 | 4 | 4 | 4 | 4 |
| Non-life | 4 | 4 | 4 | 4 | 4 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 2 | 1 | 0 | 1 | 2 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
4 | 42 | - 1 | 25 | 13 |
| Net fee and commission income | - 1 | - 1 | - 1 | - 1 | - 1 |
| Net other income | - 4 | - 3 | - 7 | - 1 | 1 |
| TOTAL INCOME | - 76 | - 49 | - 85 | - 52 | - 22 |
| Operating expenses (excluding Opex allocated to insurance service | - 52 | - 36 | - 36 | - 70 | - 35 |
| ) Total Opex without bank and insurance tax |
- 53 | - 37 | - 37 | - 70 | - 36 |
| Total bank and insurance tax | 0 | 0 | 1 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 1 | 1 | 1 | 0 | 1 |
| Insurance service expenses before reinsurance | - 2 | - 1 | 1 | 1 | - 1 |
| Of which Insurance commissions paid | 0 | 0 | 0 | 0 | 0 |
| Non-life | - 2 | - 1 | 1 | 1 | - 1 |
| of which Non-life - Claim related expenses | - 2 | - 1 | 2 | 2 | - 1 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Net result from reinsurance contracts held | - 18 | - 6 | 10 | 5 | - 6 |
| Impairment | - 1 | 1 | 4 | - 4 | 2 |
| on FA at amortised cost and at FVOCI | - 1 | 1 | 4 | 0 | 2 |
| other | 0 | 0 | 0 | - 4 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | - 150 | - 92 | - 105 | - 120 | - 62 |
| Income tax expense | 36 | 30 | 26 | 43 | 21 |
| RESULT AFTER TAX | - 114 | - 61 | - 80 | - 77 | - 41 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | - 114 | - 61 | - 80 | - 77 | - 41 |
| Banking | - 81 | - 59 | - 92 | - 71 | - 50 |
| Insurance | - 24 | - 16 | - 4 | - 9 | - 11 |
| Holding activities | - 9 | 13 | 16 | 3 | 20 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 0 | 0 | 0 | 0 | 2 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 21 550 | 22 938 | 22 898 | 20 924 | 19 986 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 1 241 | 1 243 | 1 335 | 1 380 | 1 876 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 48 | 2 | - 65 | - 22 | 2 |
| Allocated capital (end of period) | 87 | 138 | 81 | 134 | 215 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 2 300 | 3 402 | 2 725 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 61 | - 64 | - 40 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 401 | 415 | 417 |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the period (D) |
401 | 415 | 417 | |
| Basic = (A-B) / (C) (in EUR) | 5.58 | 8.04 | 6.44 | |
| Diluted = (A-B) / (D) (in EUR) | 5.58 | 8.04 | 6.44 | |
Gives insight into the technical profitability of the short-term non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio is defined net of reinsurance.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Non-life PAA – Claims and claim related costs net of reinsurance (A) |
Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
1 015 | 1 204 | 874 |
| + | ||||
| Costs other than claims and commissions (B) | Note 3.6, component of 'Insurance Service Expenses' & of 'Non-directly attributable income and expenses' & of 'Net result from reinsurance contracts held' |
531 | 676 | 496 |
| / | ||||
| Non-life PAA - Net earned expected premiums received (C) | Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
1 729 | 2 160 | 1 606 |
| = (A+B) / (C) | 89.4% | 87.0% | 85.3% |
A risk-weighted measure of the group's solvency based on common equity tier-1 capital (the ratios given here are based on the Danish compromise). Changes to the capital rules are gradually being implemented to allow banks to build up the necessary capital buffers. The capital position of a bank, when account is taken of the transition period, is referred to as the 'transitional' view. The capital position based on full application of all the rules – as would be the case after this transition period – is referred to as 'fully loaded'.
A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an impression of the relative cost efficiency (costs relative to income without banking and insurance tax, but including insurance commissions paid) of the group.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Total Opex without bank and insurance tax (A) | Consolidated income statement | 3 272 | 4 438 | 3 269 |
| + | ||||
| Insurance commissions paid (B) | Note 3.6, component of 'Insurance Service Expenses' |
280 | 340 | 246 |
| / | ||||
| Total income (C) | Consolidated income statement | 8 303 | 11 224 | 8 550 |
| =(A+B) / (C) | 42.8% | 42.6% | 41.1% |
Where relevant, we also exclude the exceptional and/or non-operating items when calculating the cost/income ratio. This calculation aims to give a better idea of the relative cost efficiency of the pure business activities. The adjustments include: MTM ALM derivatives (fully excluded), bank and insurance taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 47% in 9M 2024 (versus 49% in 2023 and 48% in 9M 2023).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. The numerator and denominator in the formula relate to all impaired loans, but may be limited to impaired loans that are more than 90 days past due (the figures for that particular calculation are given in the 'Credit risk' section.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Stage 3 impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
1 976 | 1 888 | 1 873 |
| / | ||||
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 292 | 4 221 | 4 065 |
| = (A) / (B) | 46.0% | 44.7% | 46.1% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) |
'Consolidated income statement': component of 'Impairment' |
157 | - 9 | - 5 |
| / | ||||
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
205 108 | 200 270 | 199 988 |
| = (A) (annualised) / (B) | 0.10% | 0.00% | 0.00% | |
| *based on YTD view |
Note: a negative % is a release
In 9M 2024, the credit cost ratio without the outstanding ECL for geopolitical and macroeconomic uncertainties, amounts to 0.16% (versus 0.07% in 2023 and 0.08% in 9M 2023).
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12. Where appropriate, the numerator in the formula may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12). Relevant figures for that calculation are given in the 'Credit Risk' section.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 292 | 4 221 | 4 065 |
| / | ||||
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
207 263 | 202 953 | 202 389 |
| = (A) / (B) | 2.1% | 2.1% | 2.0% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio. A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period. It is the average of 12 end-of-month LCR figures.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
100 353 | 101 555 | 100 291 |
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) |
63 164 | 63 805 | 64 119 | |
| = (A) / (B) | 159% | 159% | 157% | |
KBCs large stock of high-quality liquid assets (approximately 100 billion euros in 9M 2024), which consist of cash and bonds which can be repoed in the private market and at the central banks. Note that the 100 billion euros consist of:
• 43 billion euros (or 43%) 'Cash & Central Bank receivables' (= liquidity that could at all times be used instantaneously to cover outflows)
• 57 billion euros (or 57%) 'LCR eligible bonds' which are reported at fair value at all times, independent of IFRS classification
Gives an idea of the magnitude of (what are mainly traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
188 623 | 183 613 | 181 821 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions and investment firms' |
1 102 | 763 | 2 432 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (not with Central Banks) (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
5 783 | 6 681 | 6 901 |
| + | ||||
| Other exposures to credit institutions (D) | 3 401 | 3 301 | 3 198 | |
| + | ||||
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
10 156 | 10 263 | 9 917 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
2 487 | 2 483 | 2 537 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 1 867 | - 1 927 | - 1 969 |
| + | ||||
| Non-loan-related receivables (H) | - 748 | - 528 | - 567 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 1 672 | - 1 694 | - 1 882 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) |
207 264 | 202 954 | 202 389 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
3 764 | 4 812 | 3 614 |
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of 'Total assets' |
236 872 | 231 869 | 230 836 |
| = (A) (annualised x360/number of calendar days) / (B) | 2.09% | 2.05% | 2.06% |
The net interest margin is the net interest income of the banking activities, excluding dealing rooms and the net interest impact of ALM FX swaps and repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Regulation (EU) 2019/876 dd. 20-05-2019 | 222 448 | 208 412 | 210 651 |
| / | ||||
| Required amount of stable funding (B) | 157 245 | 153 372 | 151 289 | |
| = (A) / (B) | 142% | 136% | 139% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or number) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 21 435 | 22 010 | 21 614 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) |
Note 5.10 | 396 | 409 | 414 |
| = (A) / (B) (in EUR) | 54.08 | 53.88 | 52.17 |
KBC Group launched a share buyback program for the purpose of distributing the surplus capital from 11th August 2023 until 31st July 2024, for a maximum amount of 1.3 billion euros. At the end of September 2024, the total number of shares entitled to dividend reduced with 20 980 823 shares.
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 1 359 | 1 866 | 1 392 |
| / The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
8 735 | 8 343 | 8 246 | |
| = (A) annualised / (B) | 20.7% | 22.4% | 22.5% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 620 | 763 | 661 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 118 | 2 165 | 2 168 | |
| = (A) annualised / (B) | 39.1% | 35.0% | 40.4% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 576 | 676 | 498 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 692 | 2 705 | 2 688 | |
| = (A) annualised / (B) | 28.5% | 25.0% | 24.7% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 2 300 | 3 402 | 2 725 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 61 | - 64 | - 40 |
| / | ||||
| Average parent shareholders' equity (C) | 'Consolidated statement of changes in equity' | 21 722 | 21 164 | 20 967 |
| = (A-B) (annualised) / (C) | 13.7% | 15.8% | 17.1% |
In 9M 2024, the return on equity amounts to 14% when including evenly spreading of the bank taxes throughout the year and excluding one-offs.
Total sales of life insurance compromise new business of guaranteed interest contracts, unit-linked investment contracts and hybrid contracts.
| Calculation (in millions of EUR or %) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Guaranteed Interest products | 819 | 979 | 682 | |
| + | ||||
| Unit-Linked products | 1 228 | 1 218 | 867 | |
| + | ||||
| Hybrid products | 130 | 131 | 94 | |
| Total sales Life (A)+ (B) + (C) | 2 176 | 2 328 | 1 643 |
Measures the solvency of the insurance business, as calculated under Solvency II. A detailed calculation can be found under 'Solvency banking and insurance activities separately' section.
Total assets under management (AuM) consist of direct client money (Assets under Distribution towards retail, private banking and institutional clients), KBC Group assets (incl. pension fund), fund-of-funds assets and investment advice. Total AuM comprise assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence determine a large part of any change in this income line.
| Calculation (in billions of EUR or quantity) | Reference | 9M 2024 | 2023 | 9M 2023 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 240 | 218 | 202 |
| + | ||||
| Czech Republic Business Unit (B) | 19 | 17 | 17 | |
| + | ||||
| International Markets Business Unit (C) | 10 | 9 | 8 | |
| A)+(B)+(C) | 269 | 244 | 227 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.